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ABSTRACT
Biotechnology has had a short but rather conflict-ridden history. The technology
was commercialized in 1995 and since has become a volatile topic for international
debate. Arguably, the United States is the biggest supporter of this technology. The
United States conducted the first study using recombinant DNA, grows more biotech
crops than any other country, and houses the vast majority of the largest biotech
corporations. Proponents frequently claim that biotech crops are a way to improve crop
production, lower food prices, decrease the need for petrochemical inputs, and alleviate
international food security problems. Others see them as accelerating the loss of
traditional agricultural techniques, raising the costs of agricultural production, increasing
inequalities, and posing significant environmental and human health risks. The European
Union has been more hesitant than the United States to adopt the use of biotechnology,
which has resulted in open, international conflict. Given the novelty of and gross conflict
over this technology, deeper analyses are needed before many of these concerns can be
alleviated or substantiated.
Examining public concern can provide a rich description of the issues surrounding
biotechnology. Since the emergence of biotechnology, the European Union, via the
Eurobarometer, has frequently administered surveys to its members to measure public
concern. Conversely, the United States has failed to systematically administer surveys to
measure concern over biotechnology. Instead, US studies have tended to be ad hoc, atheoretical, and noncumulative, which has thwarted the evolution of a well-developed
literature on US public concern for biotechnology. Therefore, the aim of this study is to
examine US public opinion data to identify the dimensions inherent in the indictors of
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social concern surrounding biotechnology. Questionnaires administered between 1993
and 2010 containing at least one measure of biotech concern were collected. To identify
the dimensions of concern, a thematic content analysis was conducted on the opinion
questions. Public concern was measured by the percentage of people that express
concern in their responses to the questions. I also examine trends in concern, as they
relate to the dimensions of concern proxied by the indicators.
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CHAPTER 1
INTRODUTION
Biotechnology is an ambiguous concept that cannot be easily defined (Peacock
2010). Since the birth of biotechnology in 1972, numerous definitions have been offered.
The first US federal regulatory document on biotechnology states that it “includes
recently developed and newly emerging genetic manipulation technologies, such as
rDNA, rRNA, and cell fusion” (Office of Science and Technology 1986:3). The United
Nations Convention on Biological Diversity offers a broader definition, defining
biotechnology as “any technological application that uses biological systems, living
organisms, or derivatives thereof, to make or modify productions or processes for specific
use” (Peacock 2020:323). Defining biotechnology is further complicated by the
numerous terms often used synonymously with it: genetic modification, genetic
engineering, and genetic alteration (see Union of Concerned Scientists 2009). To
illustrate why scholars have not agreed upon a single definition of biotechnology, Table 1
lists some of the various definitions that have been used.
The Pew Initiative on Food and Biotechnology (2001) offers a general definition
of biotechnology, referring to it as “the use of recombinant DNA to transfer genetic
material from one organism to another” (P.i). Recombinant or rDNA refers to the hybrid
genetic material that results from the combination of different organism’s genetic
material (Smith 2009). Often rDNA is derived from taking genetic material from
different species; the resulting organism is referred to as transgenic (Grace 2006; Levine
III 1999). Although there are numerous techniques used to extract, combine, and insert
the genetic material (Food Insight 2009), the central aim of biotechnology is to produce
new, improved organisms that can be used to make various products (Dudley 1990).
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Table 1. Scholarly Definitions Offered for Biotechnology
Source
Definition
(Asian Development Bank
“Any technique that uses living organisms or substances from those
2001:195)
organisms to make or modify a product, to improve plants or animals, or to
develop microorganisms for specific uses. These tech- niques include the
use of new technologies such as recombinant DNA, cell fusion, and other
new bioprocesses.”
(Avise 2004:202)

“The use of living entities or their components or products for industrial or
commercial applications.”

(Dudley 1990:252)

“[T]he use of living organisms to manufacture products”

(Food and Water Watch
2011:1)

“[I]nvolves manipulating the genetic makeup of plants or animals to create
new organisms.”

(Grossman 2003:86)

“[I]s any technological application that uses biological systems, or
derivatives thereof, to make or modify products or processes for special
use.”

(Persley 1993:477)

“[A]ny technique that uses living organisms or substances from those
organisms to make or modify a product, to improve plants or animals, or to
develop micro-organisms for specific uses.”

(Pew Initiative on Food and
Biotechnology 2012:1)

“[A] set of biological techniques, particularly rDNA techniques, developed
through basic research and now applied research and product
development.”

(Herdt 2006:266)

“[R]efers to the DNA-based molecular techniques used to modify the
genetic composition of agriculturally useful plants and animals.”

(Union of Concerned
Scientists 2009:41)

“Technology related to the manipulation of living organisms. Often used
interchangeably with genetic engineering and genetic modification.”

(Wheale and McNally
1995:261)

“[T]he application of scientific and engineering principles to the processing
of materials by biological agents to provide goods and services.”

(Secretariat of the
Convention on Biological
Diversity 2000:4)

“[T]he application of… in vitro nucleic acid techniques, including
recombinant deoxyribonucleic acid (rDNA) and direct injection of nucleic
acid into cells or organelles, or fusion of cells beyond the taxonomic family,
that overcome natural physiological reproductive or recombination barriers
and are not techniques used in traditional breeding and selection.”
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To alleviate some of the ambiguity in defining biotechnology, some scientists
have divided the field into red, green, white, and blue (Peacock 2010). Red, or medical
biotechnology, entails the use of plants to produce medicinal compounds (known as
pharming) and the use of animals to produce organs for transplant or vaccines. Green, or
agricultural biotechnology, also entails the use of plants or animals but for improving
food production (e.g. increasing yields and pest-resistance, nutritional quality, or droughtresistance). White, or industrial biotechnology, uses natural processes like fermentation
or enzymes to create new products; bioplastics made from vegetable oils instead of
petroleum is one example (Peacock 2010). Lastly, blue biotechnology utilizes aquatic
organisms. For example, Aquabounty’s AquAdvantage salmon combines genes from the
ocean pout and the Chinook salmon to create a faster-growing breed of salmon (Food and
Water Watch 2011). Breaking biotechnology into these different sectors aids in
conceptualizing its various components.
The sheer volume of biotech products in the global food supply indicates the
importance of understanding biotechnology. In 2009, 77 percent of soybeans, 49 percent
of cotton, 26 percent of maize, and 21 percent of canola grown globally was
bioengineered (International Service for the Acquisition of Agro-biotech Applications
[ISAAA] 2010a). Currently, biotech crops are the fastest adopted crop technology
(Penchlaner and Otero 2008), and in 2010, 336 million acres were grown in over 29
countries, which accounted for 10 percent of global cropland (Food and Water Watch
2011). Figure 1 illustrates trends in the global growth of biotech crops.
The rapid growth and widespread adoption of biotechnology gives rise to
questions regarding the human and ecological safety of this technology. The United
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Figure 1. Global Area of Biotech Crops Grown, 1996-2010
(ISAAA 2011)
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States is the largest supporter of biotechnology (Bhargava 2002; Peacock 2010;
Penchlaner and Otero 2008). In 2009 the United States was responsible for 47 percent of
biotech crops grown globally (ISAAA 2010b) and was ranked as the top country for
biotech innovation (Scientific America 2009). Additionally, among the top 15 countries
engaged in commercial biotechnology in 2007, the United States housed 29 percent of the
biotech corporations (Peacock 2010).
In contrast to the United States’ seeming embrace of biotechnology, the European
Union contests the use of biotechnology. One-fourth of EU members currently have a
ban on the sale and growth of biotech products, and in 2009 only .05 percent of EU fields
cultivated biotech crops (Food and Water Watch 2011). Considering these stark
differences, it is possible that Europeans are more concerned about biotechnology than
US residents.
Since 1991, the European Commission (2010) has systematically studied EU
member’s concern for biotechnology via the Eurobarometer. Results have indicated that
in Europe, food biotechnology is not perceived as just another technology but triggers
unease and fears about long-term consequences (Barling et al. 1999). Unfortunately the
United States has failed to undergo such a systematic study, which has thwarted the
development of a coherent literature about US biotech concern (Lusk et al. 2005). The
rich variety of biotech applications (Listerman 2010) has resulted the emergence of
numerous ad hoc, atheoretical and non-accumulative studies. Due to the lack of
formalization in the conception and measurement of US biotech concern, there is a need
for a framework to unite the existing, fragmented studies.
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THE AIMS OF THIS STUDY
In this study, I offer a framework to conceptualize and measure US concern for
biotechnology. Specifically, the aims of this study are as follows:
Aim One: Identify the dimensions of biotech concern
Aim Two: Examine if and how concern varies across dimensions and over time.
To accomplish Aim One, I relied heavily on the framework to conceptualize and
measure environmental concern set forth by Dunlap and Jones (2002). According to their
framework, environmental concern is comprised of two components: the environmental
and concern component. To conceptualize the concern component, they draw from
attitude theory, and to operationalize it, they use a scale developed by Maloney and Ward
(1973). In developing my framework, I retain their conceptualization and measurement
of concern. Because biotechnology and the environment are different subjects, I could
not rely as heavily on their conceptualization and measurement of the environmental
component. Instead, I had to identify the various dimensions of biotechnology.
To aid in identifying the various dimensions, I conducted an extensive literature
review on biotech concern. Chapters two and three are results of the literature review and
examine the development of biotechnology and the controversy over its growth. These
chapters aided in identifying the dimensions of biotechnology by providing an historical
context and examining conflicting arguments over its development.
Along with the literature review, I collected and analyzed 22 US questionnaires
that asked about biotechnology. The questionnaires were administered between 1993 and
2010, and all relied on a national, random sample of adults. I conducted a content
analysis of the questions about biotechnology, identifying the object of study in each
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question. In conjunction with the major divisions expressed in the literature, codes were
developed for the objects identified. The codes came to represent the various dimensions
of biotechnology. Chapter four provides a greater discussion on the framework I
developed, Dunlap and Jones’s (2002) framework, and the collection and analysis of US
questionnaires.
To accomplish Aim Two, I examined how concern varied across the dimensions
and over time. Not all questions used to identify the dimensions were used in this
analysis. This is because not all question about biotechnology indicate concern. For
example, a 1998 study conducted by Miller asked, “[H]ow well informed would you say
you are about biotechnology?” A well-informed person may or may not be more
concerned about biotechnology, and so the question was not taken to be an indicator of
concern. Of those that were, the degree of concern was exemplified by the percent of
respondents that expressed concern. Decision rules were developed to determine how
concern is measured with each question type. For example, on a 7-point Likert scale,
scores of 5-7 were taken to indicate concern, a score of 4 indifference or ambivalence,
and scores of 1-3 a lack of concern. I used robust regression to determine if the percent
concern expressed is greater, less, or the same if some dimensions are measured relative
to others. I also examined whether or not concern has changed over time, when
dimensions are controlled. This is expanded upon in chapter five. The concluding
chapter discusses the results of the study, its strengths and weaknesses, and possible
directions for future research.
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CHAPTER II
THE RISE OF BIOTECHNOLOGY
Currently, the United States and the European Union have very different policies
that regulate biotechnology. The United State’s policies have been criticized for not
being stringent enough, while the European Union’s policies have been criticized for
being too stringent (see McGiffen 2005; Sheingate 2006). The European Union’s
policies, however, have not always been as resistant to biotech development as often
depicted today (see Vogel 2001). As early as 1986 (Dibner), Europe was cited as a top
biotech developer, had numerous government-sponsored development programs, and
strongly emphasized “the potential to become a strong competitor in the long run”
(1372). Although both the United States and the European Union were top developers in
the 1980s, their policies have since diverged (Kalaitzandonakes 2000). The intent of this
chapter is to explore the development of US and EU policies to aid in understanding the
roots of these differences.
The United States has a product-risk approach to policy, while the European
Union adheres to the precautionary principle. At surface-value, the product-risk
approach and the precautionary principle seem to have similar objectives
(Kalaitzandonakes 2000). Both are based on scientific assessment and entail a similar
methodological approach: hazard identification, evaluation of the likelihood and potential
impact of adverse effects, and risk characterization (see Secretariat of the Convention of
Biological Diversity 2000; Randall 2011; Sheldon 2003; Shelton, Zhao, and Roush
2002). Risk characterization entails a description of the nature of the adverse effects and
the strength of the evidence supporting the characterization (Randall 2011:44). Although
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both approaches apply a similar methodology to scientific assessment, the precautionary
principle focuses more on preventing harm.
The EU approach is more risk-averse than the US approach (Vogel 2001). The
US product-risk approach “consists of the identification of hazards and the analysis and
evaluation of those risks associated with exposure to those hazards” (Fraser n.d.). Key
elements of the precautionary principle, however, include taking precaution during
scientific uncertainty, exploring less harmful alternatives, shifting the burden of proof to
the developer, and employing democratic procedures to enforce the principle (Randall
2011). Although the US approach claims to contain the same elements, it has been
criticized for simple approval procedures (see McGiffen 2005; Vogel 2001), fostering
corporate growth and control over markets (Moses 1999; Sheingate 2006), and ignoring
public concerns (see Alliance for Bio-Integrity 1999). Additionally, the US approach has
been criticized as equating risk assessment with scientific assessment and using the label
of science to legitimate marketing new products (Jasanoff 2005). The precautionary
principle, however, has been criticized as a form of protectionism (Sheingate 2006).
Although biotechnology may have “began similarly on both sides of the Atlantic,”
it “quickly took different paths” (Vogel 2001:3). The remainder of this chapter explores
the birth, growth, and development of biotechnology in the United States and the
European Union. Placing US and EU policy development within an historical context
offers a greater understanding of current policies. See appendix A for a timeline of
biotech development.
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THE BIRTH OF BIOTECHNOLOGY
Paul Berg, a biochemist at Stanford University, conducted the first experiment
using rDNA in 1972. Berg’s previous work on enzymes, DNA, and ribonucleic acid
molecules led him to wonder about transferring genes between species; it was his
curiosity that compelled him to conduct this landmark experiment (Chemical Heritage
Foundation 2010). Berg combined DNA from monkey virus SV40 with lambda, a
bacteriophage. He intended to insert the new genetic material into a bacterium of E. Coli,
but his colleagues convinced him to delay the experiment until a consensus was reached
about how to proceed safely (Peacock 2010). Because Berg’s experiment, as well as
much of the early work using rDNA, involved viruses and bacteria, there was much
concern about creating carcinogenic viral genes or new bacterial strains (Pew Initiative
on Food and Biotechnology 2001).
To address these risks, Berg, in conjunction with the National Science
Foundation’s Human Cell Biology Steering Committee and the National Cancer Institute
of the National Institutes for Health (NIH), organized the 1973 Asilomar Conference. At
the conference, it was decided research should continue with caution and that potential
risks should be quantified (Pew Initiative on Food and Biotechnology 2001). This
conference also led to the creation of the Recombinant DNA Advisory Committee (RAC)
in 1974. The RAC was established to assess and report to the director of NIH, “the state
of knowledge and technology regarding DNA recombinants, their survival in nature, their
transferability to other organisms, and their societal impact” (Pew Initiative on Food and
Biotechnology 2001:5).
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In 1975 Berg organized the second, better-known, Asilomar Conference. The
focus of the previous conference was on carcinogenic risk; however, the focus of the
second conference encompassed overall risk (Pew Institute on Food and Biotechnology
2001). Conference participants included lawyers, an international group of 150 scientists,
and 16 journalists (US National Library of Medicine 2012). Conference discussions
centered on establishing a containment categorization scheme that corresponded to
estimated levels of risk (Barkley and Chase 1997). These discussions informed the 1976
guidelines published by the RAC, which recommended different containment levels for
different experiments (Office of Technology Assessment 1986).
The RAC was responsible for regulating biotechnology until 1984. In 1982,
scientists from the University of California, Berkeley submitted a proposal for the fieldtesting of Ice Minus, a bacterium engineered to slow the formation of ice crystals on
strawberry plants, thus mitigating crop losses (Sheingate 2006). The application was
narrowly approved in 1983, and in 1987 Ice Minus became the first biotech organism to
be released into the environment (Peacock 2010). This highly controversial decision
heightened public attention and concern over the use of biotechnology (Sheingate 2006).
In response to growing concerns, the Reagan Administration established the
White House Cabinet Council on Natural Resources and the Environment (CCNRE),
currently known as the Domestic Policy Council Working Group on Biotechnology. The
CCNRE was created to determine if a new framework needed to be developed to regulate
the production and research of biotechnology (Patterson 1999). Additionally, CCNRE
asked the NIH to cease evaluating biotech organisms for release into the environment
(Sheingate 2006). In 1984, the CCNRE published a proposal for the regulation of
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biotechnology in the Federal Register and called for public comments, which were
reflected in their 1986 policy statement, the Coordinated Framework for the Regulation
of Biotechnology (Patterson 1999:19).
The 1986 Coordinated Framework for the Regulation of Biotechnology was the
first US federal regulatory statement issued specifically about biotechnology. Although it
was only a statement of policy and established no new regulations (Pew Institute on Food
and Biotechnology 2001), it set the precedent for current regulations. The framework
established two main principles: existing statutes are sufficient for regulation, and
regulation is for the product, not the process (Pew Institute on Food and Biotechnology
2001). These two principles and the framework that established them are still the basis
for the United State’s regulation of biotechnology.
According to the framework, the Federal Food and Drug Administration (FDA)
determines if biotech products are safe for consumption, the Environmental Protection
Agency (EPA) ensures that the use of biotechnology is safe for the environment, and the
US Department of Agriculture (USDA) decides whether biotech products are safe for use
with animals. The NIH is still responsible for regulating biotech studies that receive
federal research monies. Table 2.1 details the regulatory responsibilities allocated to
these agencies.
Under the 1938 Federal Food, Drug, and Cosmetic Act (FD&C), the FDA was
granted responsibility for the safety of food and drugs for both humans and animals (Pew
Institute on Food and Biotechnology 2001). Despite the different processes involved in
biotechnology and conventional breeding, the FDA stated that its “administrative review
of products” should be “conducted in the light of the intended use of the product on a
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Table 2.1 Descriptions of US Regulations
Agency
Policy
Federal Food
1938 Federal Food, Drug, and
and Drug
Cosmetic Act (FD&C)
Administration
(FDA)

Environmental
Protection
Agency (EPA)

US
Department of
Agriculture
(USDA)

National
Institutes of
Health (NIH)

Description
Required developers to demonstrate the safety of
drugs prior to marketing, extended authority to
include color additives and cosmetics, established
labeling requirements, and set tolerance levels for
risky substances

1992 Statement of Policy: Foods
Derived from New Plant
Varieties

Clarification of interpretation of FD&C with regard to
biotechnology

2001 Premarket Notification
Proposal

Required developers to submit scientific and
regulatory assessment of biotech product 120 days
prior to marketing

1938 FD&C

In 1970, relieved most of the FDA’s responsibility for
setting and enforcing tolerance levels for risky
substances

1972 Federal Insecticide,
Fungicide, and Rodenticide Act

Aimed to protect consumers from risky products and
deceptive labeling, established authority to oversee
sale and use of pesticides

1976 Toxic Substance Control
Act

Aimed to limit or prohibit the manufacturing,
processing, distribution, use, and disposal of risky
industrial chemicals

1912 Plant Quarantine Act

Regulated interstate trade of nursery stock and plants

1957 Federal Plant Pest Act

Extended regulatory authority to include the foreign
trade of nursery stock and plants

1975 Federal Noxious Weed Act

Regulated the spread of noxious weeds by inspecting,
seizing, and destroying plants or quarantining areas as
necessary

2000 Plant Protection Act

Consolidated 10 USDA laws, including the three
listed above, established a premarket notification
process

1986 Guidelines for Research
Involving Recombinant DNA
Molecules

Regulates institutions receiving federal research
monies
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case-by-case basis,” and that they “need not establish new administrative procedures to
deal with genetic concerns about biotechnology” (Office of Technology Assessment
1986:22). Therefore, biotech products are not assessed according to the process by which
they were produced, but are considered substantially equivalent and are regulated as all
other foodstuffs.
Under the FD&C, the 1976 Toxic Substances and Control Act (TSCA), and the
1972 Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the EPA is
responsible for establishing allowable levels of pesticides in food and for ensuring that
pesticide-producing plants are not harmful. When the EPA was established in 1970, the
agency assumed most of the FDA’s responsibility for setting and enforcing tolerance
levels for chemicals. Specifically, the EPA is responsible for regulating pesticides used
in the production of food, as well as residual levels on food products in the market (EPA
2012). The EPA recognized much of the uncertainty surrounding biotech organisms (see
Office of Technology Assessment 1986). Accordingly, they made amendments to both
TSCA and FIFRA that mandated premarket notification and review; the EPA established
the Science Advisory Committee to conduct these reviews (Office of Technology
Assessment 1986).
Under the 1912 Plant Quarantine Act (PQA), 1957 Federal Plant Pest Act,
(FPPA) and the 1975 Federal Noxious Weed Act (FNWA), the USDA was granted
regulatory oversight of biotech plants, animals, and plant and animal pathogens with
respect to agriculture. The USDA, also recognizing the unique process of biotechnology,
published guidelines for conducting research, modified existing policies, and established
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the Office of Agriculture Biotechnology to implement and coordinate the new policies
and procedures (Office of Technology Assessment 1986).
GROWTH AND DEVELOPMENT
In the late 1980s, the lure of commercial success led many members of the
European Economic Community to collaborate in promoting the development of
biotechnology (see Dibner 1986). Support was provided for academic programs, new
companies entering the industry, partnerships between universities and industries, and
collaborations between European and US corporations (Dibner 1986). Additionally, it
became clear that there was a need to coordinate policies between member states. The
lack of coordinated policies limited the ability for scientists, special interest groups, and
the public to discuss important issues surrounding biotechnology (Patterson and Josling
2002). To enhance commercial development, there was a need to harmonize policies on
the release of biotech products into the environment and markets (Guehlstorf and
Hallstrom 2005).
In 1990, the European Union adopted their first coordinated policies on
biotechnology. Directive 90/219/EEC regulated biotech research and development, and
Directive 90/220/EEC regulated the deliberate release of biotech products into the
environment or market. Both directives were primarily aimed at protecting the
environment and were subjected to approval by each Member State (Bernauer and Meins
2003). Under this new system, 14 biotech products were approved, which included
mostly corn, oilseed rape, soybeans, and tobacco (Sheldon 2003). However, not all EU
members supported the approval of biotech products. Austria, France, Germany, Greece,
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Italy, and Luxembourg banned several varieties of corn and oilseed rape (Sheldon 2003).
Table 2.2 summarizes the history of EU biotech regulations
Two years after the European Union established Directive 90/219/EEC, the FDA
issued a statement of policy regarding their interpretation of existing law in regulating
biotechnology. In this statement, the FDA reaffirmed the notion of substantial
equivalence. Drawing off the FD&C, the FDA stated that all biotech foodstuff should be
described using the same terminology used to describe their traditionally derived
counterpart. More so, to avoid misleading labeling, all labels should detail only material
facts (Sheldon 2003), and not details about the process of production. The policy
statement also clarified the approval process prior to marketing biotech foodstuff. The
FDA’s statement of policy resulted in a voluntary assessment process in which the
developer of the biotech product can submitted a scientific presentation about the safety
and nutritional qualities of the product (Pew Initiative on Food and Biotechnology 2001).
In 1994, Calgene’s Flavr Savr tomato was approved and became the first biotech
product to be commercially marketed in the United States. The Flavr Savr tomato was
engineered to slow the ripening process and to increase shelf life (Paul and Stenbrecher
2003). The tomato was taken off the market in less than a year. It was not popular,
largely due to its odd consistency, but it raised consumer awareness that biotech foodstuff
had entered the food supply (see Peacock 2010:56). In 1996, the first biotech product
was approved and commercially marketed in the European Union. It was a tomato paste
derived from Calgene’s Flavr Savr tomato.
In 1997, the European Union adopted Regulation No. 258/97, otherwise known as
the Novel Foods Regulation. This regulation was established to address the human health
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Table 2.2 Descriptions of EU Regulations
Date
Policy
Description
1990
Directive 90/219/EEC
Established a process for research and development
Directive 90/220/EEC

Established a process for the assessment and approval of biotech
products for release into the environment

1997

Regulation No. 258/1997

Simplified approval procedure, required labeling for all novel food
products containing biotech ingredients

1998

Directive 98/44/EC

Established intellectual property rights for biotech inventions

2001

Directive 2001/18/EC

Replaced Directive 90/220/EC, established the safeguard clause

2003

Regulation No. 1829/2003

Required developers to submit application to be assessed by the
European Food Safety Authority for intended use and risk

Regulation No. 1830/2003

Required labeling for all food and feed containing biotech
ingredients, mandated all businesses that handle biotech products to
track them through the commercial food chain

Environmental Counsel’s
Conclusion on GMOs

Clarified the implementation of the European Union’s legal
protection of biotechnological inventions

2008
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concerns that Directive 90/219/EEC and 90/220/EEC failed to address. It established an
approval process in which the producer or importer had to show the food not to be
harmful to human health (Bernauer and Meins 2003). Specifically, the regulation applied
to new foods or food ingredients that had previously not been approved for human
consumption (European Parliament and Council of the European Union 1997).
Additionally, this regulation required both unprocessed biotech foods and those products
that contained biotech ingredients to be labeled (Sheldon 2003).
In 1998, the limitations of the European Union’s regulatory system become
apparent. The European Union’s approval of a British strain of biotech canola,
Novartis’s Bt corn, and Monsanto’s Roundup Ready Soybeans led to disputes among
member states, lengthy delays in the approval process, and bans on biotech products by
certain member states (Bernauer and Meins 2003). By April of 1998, a de facto
moratorium was placed on all new approvals. Only the European Commission, the
United Kingdom, and the Netherlands voiced opposition to the moratorium (Bernauer
and Meins 2003:651). In June of 1999, the European Union formalized the moratorium
by amending Directive 90/220/EEC to include a more precautionary approach to the
approval process (Sheldon 2003).
The European Union’s shift to a more precautionary approach coincided with the
rapid spread of “mad cow disease” in Europe. This lowered European public confidence
in the government’s ability to regulate the safety of food (Moses 1999). More so, it was
preceded by as the ramped spread of dioxin-tainted meat or “foot in mouth disease” (Pew
Institute on Food and Biotechnology 2005). The preexisting lack of public confidence
hindered EU support for the support of biotechnology.
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Concern was not only heightening in the European Union but in the United States
as well. In the United States, the StarLink controversy greatly increased consumer
awareness and concern. In 2000, Aventis CropScience engineered corn with a Bt
bacterium that warded off the European corn borer moth, a common pest. The corn was
only approved for use with animal feed, but shortly after its approval, it was found in taco
shells manufactured by Kraft Foods. This episode caused much alarm, largely because it
“showed that seeds planted on less than one percent of America’s corn acreage could
easily spread from farm to farm, contaminate the nation’s grain handling system, and
seep into global food supplies” (Peacock 2010:58).
Due to increasing public concern, the USDA sought to rework and clarify their
regulatory stance by establishing the 2000 Plant Protection Act. This act consolidated
and took the place of ten policies, including the PQA, FPPA, and FNWA. Additionally,
the USDA’s Animal and Plant Health Inspection Service (APHIS) became responsible
the safety of animal products, including food and drugs (Pew Institute on Food and
Biotechnology 2001). The act also established a pre-market approval process that
requires the developer to submit a petition, along with information on the biology and
genetics of the organisms involved, experimental data, and field test reports (US
Geological Survey 2011). Once approved, the organism can be introduced into the
environment without further regulatory oversight (Animal and Plant Heath Inspection
Service 2007). The 2000 Plant Protection Act was established to alleviate public
concerns by clarifying regulations and establishing a more ridged approval processes.
Since then, nearly 11,600 applications have been submitted to APHIS, and 92 percent
have been approved (Schneider and Schneider 2006).
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The international controversy over biotechnology peaked in 2003 when the
United States, in conjunction with Argentina and Canada, filed a formal complaint with
the World Trade Organization (WTO) against the European Union. The US government
claimed that the European Union’s anti-biotech food policies and six-year moratorium on
the approval of biotech products violated international trade agreements (Peacock 2010).
The US government argued that the European Union was not only thwarting sales in its
own counties, but had also influenced attitudes towards genetic modification in other
countries (Schurman and Munro 2010). This claim stemmed from Africa’s rejection of
the World Food Program’s aid in 2002; the aid was rejected because it contained biotech
corn from the United States. The WTO ruled in favor of the United States and the
European Union was forced to adjust their policies.
UNSETTLED SETTLEMENT
To meet the WTO demands, the European Union lifted the moratorium on biotech
products and established new policies. Directive 2001/18/EC was established and
replaced Directive 90/220/EEC. Revisions included “time limits on approval (maximum
10 years); explicit procedures and schedules for each stage of the approval process;
public registers detailing the locations of GMOs release for trial or commercialization;
stricter guidelines for risk assessment; the gradual elimination of antibiotic resistance
markers in GMOs; and calls for new and stricter legislation on traceability, liability and
labeling” (Bernauer and Meins 2003).
Additionally, the European Union adopted Regulation No. 1829 and Regulation
No. 1830. Regulation No. 1829 is a stricter version of previous regulations on food and
feed that provides a higher level of protection for human health (Europa 2011a).
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Regulation No. 1830 established a framework for tracing food products throughout the
entire food chain (Europa 2011b); products that contain biotech ingredients are traced
from production to market. This not only applies to biotech foodstuff but to all types of
products, including industrial products. According to the European Union, the
framework aids in the surveillance of labeling, monitoring potential human and
environmental health risks, and the removal of adverse products (Europa 2011b).
The WTO settlement may appear to have quelled the US and EU controversy over
biotech regulation. The European Union was forced to readjust their policies and speed
up their approval process. As of August of 2011, there were 39 biotech crops approved
for commercial use in the European Union and 72 applications pending (EuropaBio
2011). However, the regulatory approach that the European Union adheres to is still
fundamentally different than that of the United States. The European Union’s regulations
continue to adhere to the precautionary principle. Biotech products are still not approved
until it can be demonstrated that no adverse effects will result, and labeling and
traceability are still mandatory (Sheldon 2003). Although the WTO settlement did result
in a speedier approval process, the European Union’s approach to regulating
biotechnology has remained much more preventative than the United State’s product-risk
approach.
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CHAPTER THREE
BIOTECH CONTROVERSIES
Much of the literature on biotech concern focuses on the United States and the
European Union. The US public is framed as being less concerned than EU members (see
Bhargava 2002; Herdt 2006; Hoban 2004; Peacock 2010; Pechlaner and Otero 2008;
Stone 2010). A variety of reasons have been offered to explain the difference in concern.
As expanded upon in chapter three, the disparity has been explained by the different
philosophies informing policy development. Other reasons offered include the difference
in introductions to biotechnology, consumer group development, and cultural perceptions
of food.
The United States and the European Union experienced the birth of biotechnology
quite differently. The first study using rDNA techniques occurred in the United States
(Peacock 2010) and development was heavily supported (see Dibner 1986). However,
when biotechnology was introduced in Europe, public confidence in the ability of the
government to regulate the safety of food was already shaken by the “mad cow disease”
(Moses 1999), as well as the ramped spread of dioxin-tainted meat and the “foot in mouth
disease” (Pew Institute on Food and Biotechnology 2005). The preexistent lack of public
confidence hindered EU support for the adoption of biotechnology (Guehlstorf and
Hallstrom 2005; Stone 2010).
Additionally, consumer groups in Europe developed differently than those in the
United States. The EU public’s opposition towards biotechnology may be most strongly
related to the efforts of the consumer groups that also oppose it. (Hoban 1997:233). EU
consumer groups tend to have extensive memberships and work closely with the media to
publicize their views (Barling et al. 1999). In the United States, however, consumer

22

groups have tended to form partnerships with industry, government, and universities to
support biotech development (Hoban 1997). This has resulted in EU consumer groups
having a more critical perspective towards biotechnology than US consumer groups.
Cultural differences have also been cited as a reason for the United States and
European Union’s conflicting perspectives. Europeans generally stress the naturalness of
food (European Commission 2010; Moses 1999). In most European countries, cuisines
are based on traditional foods that are connected with regional production practices, and
supermarkets have not entirely replaced local, specialized food producers (Pew Initiative
for Food and Biotechnology 2005). This sharply contrasts with the United States where
large corporations own 75 percent of food production (Holt-Gimenez and Patel 2009).
Europeans seem to have a deeper cultural connection with their food than US residents
(Pew Initiative for Food and Biotechnology 2005:8).
Although discussing the United States and the European Union as aggregated
units is useful, it masks the internal distinctions that exist. In the United States, for
example, the use and sale of biotech products is banned in the state of Maine and the
counties of Mendocino and Marin in California (Pechlaner and Otero 2008). In the
European Union, nine member states currently have evoked the safeguard clause (WHO
2012). In the debate over biotech development, viewing the conflicting claims as
fundamental components to the object of study, rather than as opposing sides, brings
more clarity to the discourse surrounding the debate (see Garland 2012:14). The
following discussion is intended to provide a description of the conflicting claims over
various dimension of biotechnology, which has both thwarted and facilitated biotech
development across the globe.
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The debate over biotech development largely consists of conflicting claims over
food and medicinal uses, human, environmental, and societal health effects, and
regulation. Although biotechnology is increasingly being employed outside food
production and medicinal use (e.g. chemical manufacturing, biofuel production, and
environmental remediation), these uses have yet to become a large part of the biotech
debate. Most people are simply unaware of them (see Bang, Foller, and Buttazzoni
2009). Potential health effects, however, are central to the debate. In the larger debate on
genetics, the safety of biotechnology has been referred to as the most important issue
being addressed (Reilly 2000). And as illustrated in the previous chapter, there is no
consensus over the regulation of biotechnology.
CONFLICTING CLAIMS OVER USE IN FOOD PRODUCTION
The simultaneous growth in population, rise in malnourished persons, and threat
of climate change has made food security an imperative issue. The world’s population
grows by one billion every 12 years (Population Reference Bureau 2010), and the number
of malnourished persons has risen over the last 15 years from 788 million to 925 million
(Food and Agricultural Organization 2010). The gravity of global food-security needs
led world leaders to pledge at the 2000 Millennium Summit “to reduce extreme poverty
and hunger by half by 2015” (Holt-Gimenez and Patel 2009:9). Biotechnology is touted
as the solution to growing food demands (Food and Water Watch 2011); proposed
benefits include enhanced nutrition in crops (i.e. bio-fortification) and productivity in
crops and animals.
Golden rice is lauded as biotechnology’s key achievement for crops with
enhanced nutritional benefits. In countries where rice is the main mode of substance,
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deficiency diseases are widespread (GMO Compass 2010). To help address this, Golden
rice was bioengineered to produce beta-carotene, a significant source of vitamin A. A
recent study conducted by Friends of the Earth, however, found 12 pounds of this rice
would have to be eaten daily to get the espoused benefit and referred to the rice as “fools
gold” (Cummings 2008:101). Although field-testing for Golden Rice began in 1998
(GMO Compass 2010), it has not been approved for commercial use (Food and Water
Watch 2011).
Whether biotech crops actually do enhance productivity is highly contested (see
Food and Water Watch 2011; Rodale Institute 2011). Some argue that high yields are not
intrinsic to seeds but are a function of inputs (Gloklany et al. 2002; Shiva 1991).
Meaning, when administered the same inputs (e.g. water, fertilizers, or pesticides),
biotech crops do not have higher yields than traditional crops. A study conducted by the
Rodale Institute (2011) found conventional and organic crops to produce yields up to four
times higher than biotech varieties.
Biotechnology’s ability to enhance productivity in farm-animals used for food
production is also contested. Animals are bioengineered to have shorter growth periods,
produce a product faster (e.g. milk), and to have a more desirable composition (Webster
1995). Possibly the most controversial example is the approval of Monsanto’s
recombinant bovine growth hormone (rbGH; Smith 2003). Approved for commercial use
in the United States in 1994, rbGH was designed to mimic the cow’s natural hormone,
Bovine Somatotropin, and to increase milk production. In 1998, a group of Canadian
scientists published a report describing how cows injected with rbGH suffered from
“birth defects, reproductive disorders, increased rates of mastitis [utter infection that
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reduces milk quality], and other problems” (Smith 2003:88). This report spurred public
concern about the harm bioengineering inflicts upon the improved animal (see Attfield
1995).
In animal agriculture, illness represents a major cause of death and suffering
(Morrison 1995; Smith 2009). To treat mastitis, as well as a host of other inflections,
farmers have increasingly relied on the use of antibiotics. In the United States, 70
percent of all antibiotics are used on farm animals; concern over weakening the effects of
antibiotics in livestock and in those that consume livestock amplified the debate over
using biotechnology with animals to enhance productivity (Peacock 2010). Additionally,
relying on bioengineering to prevent illness perpetuates the existence of the same farm
conditions that engendered the illness (D’Silva 1995).
CONFLICTING CLAIMS OVER MEDICINAL USE
The use of biotechnology for medicinal purposes has evoked little controversy
(Stone 2010). This is not because there is less concern over medical use, but rather
because biotech medicinal products have entered into the marketplace with little public
notice (see Avise 2004). Globally, bioengineering crops and animals for medicinal use is
a $100 billion dollar market (Advise 2004), and for those that have noticed, a highly
controversial issue. Progress in bioengineering animals for medicinal purposes has been
relatively slow, due to long breeding periods, low rates of success, and high costs (Herdt
2006). Progress in bioengineering crops for medicinal purposes, however, saves millions
of dollars compared to producing medicines in laboratories and is likely to continue
(Cummings 2008:36).
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Bioengineering animals for medicinal purposes have proceeded in two directions:
for the production of vaccines and for growing human organs for transplants. Biotech
vaccines are argued as safer than conventional vaccines because they are not prepared
from dead microorganism, which are known to cause allergic reactions (Grace 2006;
Smith 2009). Despite this, concerns about interspecies-transfer of diseases and viruses
have been raised. Some claim that accidental gene transfer is highly unlikely due to
natural incompatibility barriers (Persley and Peacock 1993). However in 1983, Barbara
McClintock received the Nobel Prize in Physiology or Medicine for discovering “mobile
genes” that move within the genome (Dart 1993), and in 1988, the World Bank published
a report that recognized gene transfer in animals as a reality (Dart 1993). Numerous
studies have affirmed this recognition (see McNally 1995; LeVine III 1999).
Interspecies-transfer is also a concern for using animals to grow organs for human
transplants. This area of biotechnology involves a technique known has cloning, which is
defined as “making identical copies of entities-- molecules, cells, or individuals” (Wheale
and McNally 1995). Concern over cloning did not become widespread until the first
successful animal cloning of a Scottish sheep named Dolly, in 1996 (LeVine III 1999).
Out of 277 attempts at cell fusion, Dolly was the only lamb born; currently, only two
percent of attempted clones are born healthy (Grace 2006). Since Dolly’s birth, other
animals, including horses, deer, and bulls have been cloned (Peacock 2010). Much of the
work in growing organs for transplants has been on pigs because their organs are similar
in size and physiology to humans (Avise 2004).
Pharming is the bioengineering of plants to produce substances useful for
medicinal purposes (Peacock 2010). For those that have noticed the widespread use of
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biotechnology in medical products, pharming has produced great alarm (McGiffen 2005).
Concern is primarily over gene flow between pharmed and food varieties. According to
McGiffen (2005), “It is not a question of whether contamination would happen but where
and when” (P.79). In November of 2002, the first documented case of crosscontamination occurred in Iowa; corn biopharmed by ProdiGene Corporation to produce
a pig vaccine contaminated soybeans intended solely for human consumption (Cummings
2008). After the USDA ordered the soy, valued at $2.7 million, to be destroyed, it was
discovered that the following year’s yields were also contaminated (MGiffen 2005). To
mitigate gene flow, pharmed crops must be grown at least a half a mile away from food
crops, but with bird and bees being documented as carrying pollen well over a half a
mile, this regulation has been described as “laughable” (McGriffen 2005:79).
CONFLICTING CLAIMS OVER HUMAN HEALTH EFFECTS
In North America, 70 percent of processed foods in grocery stores contain biotech
ingredients (Avise 2004:31). In the United States, 80 percent of all foods in grocery
stores contain biotech ingredients (Brown 2010). Despite the prevalence of biotech
products in the food supply, a number of safety concerns about human consumption have
been voiced. Although the safety of biotech food has been confirmed by numerous peerreview studies (Hirschler and Kelland 2012), many of these studies have been criticized
as bad science (e.g. drawing premature results, neglecting significant health effects, and
basing results off low doses of biotech food; Goldstein and Emami 2010).
For example, results from a recent study in France found that rats fed Monsanto’s
top-selling biotech corn suffered adverse health effects. Rats fed on a diet of NK603, a
corn bioengineered to be resistant to Monsanto’s Roundup herbicide, or given water with
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Roundup consistent with US tolerance standards, suffered mammary tumors, severe liver
and kidney damage, and died earlier than rats fed conventional foods (Hirschler and
Kelland 2012). The study prompted widespread criticism from expert reviewers. The
study has been criticized for using unconventional statistical methods, providing
incomplete data on the amount of food fed to and the growth rates of the rats, and not
having a large enough control group (Hirschler and Kelland 2012). The French
government has called for further investigation.
Another concern over the consumption biotech food is potential allergies.
According to the FDA’s labeling policy, biotech products are to be labeled if their
conventional counterpart is known to cause an allergy (International Food Information
Council [IFIC] 2010). However, much of the established knowledge on allergies is based
on historic analysis of individual case studies and therefore is not fully understood
(Metcalfe 2003). It is known, however, that genes create proteins, the source of allergies
(Smith 2003). In the case of biotechnology, genes are combined in new ways that
unpredictably create multiple proteins (Smith 2003). With no historical analysis of
allergies to biotech products and no sound method to test allergic potential, there is
concern that biotech foods will unknowingly cause allergic reactions in consumers.
Food contamination is another concern. There have been multiple incidents
where biotech food only approved for use as feedstock was found in human food. The
Starlink incident is a good example of how quickly biotech products can contaminate the
human food supply. In 1998 StarLink, a variety of corn bioengineered by Aventis to
produce its own pesticide, was approved by the EPA for only use as animal feed. In
2000, StarLink corn was first found in taco shells and later in other processed foods
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(Schneider and Schneider 2006). Although Aventis spent $150 million in cleanup, corn
shipments to Bolivia, Japan, and South Korea were identified as contaminated as well
(Cummings 2008). Most recently, in 2006 Bayer’s Liberty Link rice that was not
approved for commercial use was found in the US food supply (Cummings 2008).
CONFLICTING CLAIMS OVER ENVIRONMENTAL HEALTH EFFECTS
With over 600 registered chemicals releasing five-to-six billion pounds of
pollution into the environment annually (Cummings 2008), pesticide use in agricultural
production has become a salient issue. Of the 17,000 different pesticides for both
agricultural and nonagricultural use currently on the market, the EPA has required the
testing of less than one percent (Rodale 2011). Biotech proponents have argued that
pesticide-resistant plants reduce the volume of pesticides released into the environment
(Herdt 2006), but others have argued that because seeds only control for certain pests, the
need for additional pesticides is not entirely eliminated (Quaim 2009). Additionally,
pesticide-resistant plants have been linked to the evolution of 197 species of pesticideresistant weeds (Rodale Institute 2011). These “super weeds” have contributed to
farmers becoming “trapped in a revolving door” of reliance on biotech products,
chemical use, and evolving pesticide resistance (Avise 2004:74).
The use of petrochemicals in agriculture is problematic not only because
petroleum is not renewable at rates even close to extinction rates (Cable 2010), but also
because petrochemicals do not occur in nature and cannot be broken down naturally.
Petrochemicals disrupt normal biochemistry, and can cause mutations, cancer, and
defects in the nervous system of organisms (Cable 2010:65). Furthermore, recent
research suggests that petrochemicals can provoke hormone changes that can be passed
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onto offspring (Montague 2006). Petro-dependent agriculture literally poisons the
environment and those living in it (Cable 2010).
Biodiversity is important for many reasons: it aids in water purification, mitigates
soil erosion, reduces the severity of the effects of climate change, and offers the
“multiplicity of interactions necessary to heal ecological disturbances” (Shiva 1991).
Human induced environmental changes, however, are causing plants and animals to
become extinct at rates 50 to 100-times faster than expected natural rates (Kate and Laird
2000). Globally, nearly 17,000 species are threatened with extinction (International
Union for the Conservation of Nature 2009). Biotechnology has been claimed to
preserve biodiversity by making biotech varieties of local varieties (Qaim 2009). Several
studies, however, have linked biotechnology to the decline of a number of species,
including lacewing larvae, monarch butterflies (Shelton, Zhao, and Roush 2002), and
European songbirds (Cummings 2008).
Additionally, the increasing growth of large monocultures has been linked to
adoption of biotech seeds that essentially breed uniformity in plants (Shiva 1991). Large
monocultures, for which biotech products are designed, greatly contribute to the
degradation of soil. Monocultures have been shown to damage land, leave crops
vulnerable to pests and diseases, and require heavy applications of pesticides (Peacock
2010). Despite this, monocultures have been praised as having higher yields, producing
more uniform crops, and easing crop maintenance (Peacock 2010). This praise, however,
neglects broader environmental health issues. With five billion acres of degraded soil
worldwide (Cummings 2008), attention on alternative agricultural techniques (e.g.
intercropping and integrative pest management) is increasing.
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Another concern is over the transfer of genetic material between biotech crops
and natural varieties. According to the EPA and others, there is not a reasonable
possibility of biotech varieties passing their traits to wild varieties (see Persley and
Peacock 1993; Shelton, Zhao, and Roush 2002; The National Academy of Science 1990).
Between 1990 and 2005, however, there were 115 documented cases of contamination
just in the United States (Cummings 2008). Cross-contamination is only partially
explained by wind, birds, bees, and the like. Because up to 10 percent of genetic material
may remain in the soil after harvest (Dart 1993), DNA from biotech crops can remain in
soil for several years after being introduced (Shelton, Zhao and Roush 2002). Open-field
testing of biotech crops not yet commercially approved has significantly contributed to
concerns over cross-contamination.
CONFLICTING CLAIMS OVER SOCIAL HEALTH EFFECTS
In 2008, the chief executive of Genetic Engineering Technology, Inc., better
known as Genentech, called biotechnology “one of the biggest money-losing industries in
the history of mankind… [having] lost something like $100 billion since it was first
invented” (Cummings 2008:53). Between 1999 and 2001, biotechnology cost the US
economy $12 billion in exports (Soil Association 2002). Overproduction of biotech food
in the United States has greatly contributed to lowered commodity prices, reduced the
value of land, and resulted in a loss of market shares (Brumby, Pritchard, and Persley
1993). This has caused farm subsidies to rise, costing taxpayers $3 to $5 billion annually
(Cummings 2008:27). Due to massive financial loss, suicide became the number-one
cause of death on American farms (Dyer 1998). This begs the question, who is
benefitting from the increasing adoption of biotech practices?
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Some claim agriculture is going through another revolution, a genetic revolution
(Shelton, Zhao, and Roush 2002). The “Gene Revolution” posed an opportunity to
catalyze a second Green Revolution (Schurman and Munro 2010), which was seized
largely by the Rockefeller Foundation and the Gates Foundation (Cummings 2008). The
Green Revolution was a Northern economic development model employed to
industrialize the global South’s agriculture, which was also largely funded by the
Rockefeller Foundation (Holt-Gimenez and Patel 2009). The Gene Revolution has been
described as a Northern economic development model primarily being sold to the South
through market transactions (Pingali and Raney 2005). The Green Revolution has been
criticized for offering technological fixes “that were too large-scale, too expensive, and
fundamentally inappropriate for the people they were ostensibly designed to help”
(Schurman and Munro 2010:11). Similarly, the gene revolution has been criticized for
thwarting the development of inexpensive, local, and sustainable agricultural solutions by
heavily investing in and promoting biotechnology (Cummings 2008:108). Other
similarities between the Green and Gene Revolution include increased reliance on
artificial inputs, farmer dependence on corporate suppliers, and preference for cash crops
over local varieties (McGiffen 2005). Although the Gene Revolution, like the Green
Revolution, focused on breeding improved varieties and expanding the use of fertilizers
and other chemical inputs, and irrigation (see Hazell 2003), the promotion of biotech
varieties was novel. Table 3 compares characteristics of the Green and Gene revolution.
Friedmann and McMichael’s “food regime” concept can be used to understand
biotechnology as a second Green Revolution. In 1987 Friedmann coined and defined the
concept as a “linear representation of agricultural modernization, underlying the private

33

Table 3. Characteristics of the Green and Gene Revolution
Characteristic
Green Revolution
Gene Revolution
Key Investors
Rockefeller Foundation
Rockefeller Foundation, Gates Foundation
Stated Objective

Increase food production

Increase food production

Main Crops Affected

Cereals, rice

Cereals, vegetables, fruits, animals, fish

Regions Developed

Developing countries

Developed and developing countries

Affected Areas

Favorable or irrigated lands

Favorable, irrigated, or marginal lands

Primary Beneficiaries

Public sector

Private sector

Criticisms

Too expensive, too large-scale

Too expensive, benefits corporations
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role of food in global political-economy, and conceptualizing key historical
contradictions in food regimes that produce crisis, transformation, and transition”
(McMichael 2009:140). According to McMichael (2009), the first food regime began in
1870 with Britain outsourcing food production to their colonies, the second began in the
1950s with the United States rerouting international food trade based on Cold War
strategies, and the third in the 1980s with the consolidation of the petrochemical and food
production industries. McMichael claims that biotechnology was pertinent to the
emergence of the third regime, has ascended to the top in technology for capitalist
agricultural development, and could be the basis of the next food regime (Pechlaner and
Otero 2008:352). According to Buttel (2001), the Friedmann-McMichael “food regime”
has proven to be one of the most resilient perspectives in agrarian studies since the 1980s.
Since biotech products first became commercially available in 1995,
biotechnology has grown into a $4.25 billion international market (McGriffen 2005).
Research, developments, and profits, however, are increasingly being concentrated in a
decreasing number of corporations (Asian Development Bank 2001). Five corporations
(i.e. AstraZeneca, Aventis, DuPont, Monsanto, and Novartis) control nearly two-thirds of
the global pesticide market, almost one-quarter of the commercial seed market, and
virtually all of the genetically modified seed market (Johnson and Melkonyan 2003).
Monopolization of the world’s food supply has resulted in unprecedented concentration
of market power and thus, profits (Holt-Gimenez and Patel 2009). As Robert Fraley,
executive vice-president of Monsanto in 1996, stated, “What you are seeing… [is] really
just a consolidation of the entire food chain” (Paul and Steinbrecher 2003:23).
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CONFLICTING CLAIMS OVER REGULATING BIOTECHNOLOGY
As discussed in the previous chapter, the global discourse over the regulation of
biotechnology largely stems from two competing philosophies: product-risk assessment
and the precautionary principle. The US product-risk approach has been criticized for
equating risk assessment with scientific assessment (Jasanoff 2005) and supporting
corporate growth and profits at the expense of human, environmental, and societal health
(see Avise 2004). The precautionary principle has been depicted as repeatedly invoked
“to support unwarranted restrictions of the safest, most intensively studied food products”
(Paul and Steinbrecher 2003:70). Although the 2003 WTO settlement may have
appeared to quell US and EU disputes over biotechnology, the regulatory approaches
have remained fundamentally different.
This difference is reflected in US and EU patent systems in ways that “critically
affect the [biotech] industry” (McGiffen 2005:82). The biotech industry greatly benefited
from the inclusion of US, and increasingly international, intellectual property rights (IPR)
among traditional property rights. Boyle (2008) has coined this “the second enclosure
movement,” as it privatizes the commons of the mind. The catalyst for this enclosure
was the 1980 US Supreme Court ruling in Diamond vs. Chakrabarty that deemed
microorganisms patentable. In 1995, IPR went global with the establishment of the WTO
and the Trade-Related Aspects of Intellectual Property Rights (TRIPS), which as
Carruther and Ariovich (2004) point out, is enshrined in US standards. Strong IPR
bolstered biotech corporations rights to the biotech process, the resulting gene, the host
into which the foreign gene is inserted, and the end organism.
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The establishment of strong IPR may benefit biotech corporations (see Schurman
and Munro 2010:36), but ample evidence suggests that it hurts small business and
individuals. For example, the development of a single biotech product may require at
least a dozen patents, entail high costs, and licenses may have to be negotiated with
multiple parties (Qaim 2009). This hinders not only developers, but smallholders as well.
Another example of harm caused by strong IPR is the loss of the Plant Breeders’ Rights
(PBR) under TRIPS. Adopting TRIPS eliminated PBR’s two main exemptions for
utilizing patented varieties: smallholders’ right to save seeds and breeders’ right to make
new plant varieties from patented varieties. This has rendered corporations considerable
control over the global food supply and smallholders. According to a report published by
the Center for Food Safety, Monsanto has an annual budget of $10 million and a staff of
75 devoted solely to investigating and prosecuting farmers, has taken out radio ads to
encourage farmers to inform on each other, and set up an informant hotline that receives
about 500 tips a year (Cummings 2008:67-68). Strong IPR are espoused as protecting
private ownership, but others claim that it privatized the commons of the mind.
Despite these numerous controversies, labeling is the most complex and
contentious regulatory issue today (Hoban 2004). In the United States, polls repeatedly
show that over 90 percent of US residents want biotech products labeled (Cummings
2008). Despite this, the United States only requires labeling when biotech food
significantly differs from its counterpart or is known to cause an allergy. Proponents of
mandatory labeling claim that consumers have a right to know what is in their food and
that labeling would raise awareness and knowledge about biotechnology (Stilwell and
Van Dyke 1999). Others view labeling as creating market segregation (Qaim 2009).

37

According to the FDA, mandatory labeling “would impermissibly interfere with
manufacturers’ ability to market their products on a nationwide basis” (McGiffen
2005:69). Along with the United States, Argentina and Canada do not have mandatory
labeling policies, whereas Austria, China, the European Union, and New Zealand do
(Peacock 2010:45).
MAKING SENSE OF THE DEBATE
Central to the debate on biotechnology is its naturalness. Often the technology is
framed as naturally progressing from conventional breeding techniques (Stone 2010).
Humans modified organisms to meet needs for thousands of years (The National
Academy of Sciences 1990), and biotechnology is part of the evolution of science
(Persley and Peacock 1993). Because scientists can control genes in a less haphazard
way, bioengineering is quicker than conventional breeding (Monsanto 1990).
Additionally, conventional breeding can only occur between closely related species
(Industrial Biotechnology Association 1990). Through scientific advancements,
biotechnology developed as an improvement over conventional breeding techniques.
However, this narrative has been criticized for conflating technology with science.
Viewing biotechnology as a natural progression in science, instead of dependent upon
science, masks the dubious assumptions on which it is built (Barling et al. 1999). For
example, it is assumed that genes are expressed in a consistent manner, affect nutrition
and allergies in predictable ways, and can be controlled once introduced into a population
(Smith 2003). Because science is the leading source of cognitive authority in modern
society (McGinn 1991), biotechnology benefited from this conflation. By blurring
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technology and science, the differences between natural and artificial life have blurred
(Cummings 2008).
The naturalness of biotechnology is at the crux of the biotech debate. Framing
biotech products as improved traditional products implies there is no reason to be
concerned about the change; the change is progress. However, if biotech products are
framed as resulting from a new technology, there is reason to be concerned about the
science behind the technology. This fundamental divide in the debate is integral to the
conflicting claims over food and medicinal uses, human, environment, and societal health
effects, and the regulation of biotechnology.
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CHAPTER FOUR
DATA AND METHODS
This chapter discusses the process of developing my framework to unite the
fragmented studies on US biotech concern. I conducted a literature review on US public
opinion on biotechnology, and I collected and analyzed 22 questionnaires that asked at
least one question US public opinion data on biotechnology. I modeled my framework
after the framework suggested by Dunlap and Jones (2002) for conceptualizing and
measuring environmental concern. I then applied my framework to further analyze the
22 studies I had collected. The questions asked in the studies are my unit of analysis.
This chapter provides a more detailed discussion of the collection and organization of the
data, the development of my framework, and its application to the 22 questionnaires I
collected.
COLLECTION OF DATA
Data from polls, reports, surveys, and questionnaires on US public opinion on
biotechnology were collected. For simplicity, I refer to all of the data as coming from
questionnaires. The questionnaires were obtained through a variety of methods. I
searched databases available through the University of Tennessee (UT) Libraries and
major research institutes, such as the Pew Research Center. I also used the Google
Search Engine and consulted journal articles for data references. Questionnaires were
included in my study if free for the public or UT students, methodology and the questions
were explicitly stated, counts or percentages for the responses were provided, and
biotechnology was specifically referred to in one or more questions. Additionally, all
data was derived form national, random samples of adults. Twenty-two questionnaires,
with publication dates ranging from 1993 to 2010, were identified using this criteria and
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are listed, along with the number of questions included from each source, in Table 4.1.
Descriptions of each study and a reproduction of my own notes can be found in Appendix
B.
DEVELOPING MY FRAMEWORK
The framework I developed to make sense of the various questionnaires I
collected was modeled off that suggested by Dunlap and Jones (2002) for understanding
environmental concern. The rationale behind employing their framework is based on the
similarities in conceptual and measurement issues in studying environmental and biotech
concern. This similarity made their framework a good model for developing a
framework to better understand US public concern for biotechnology.
The Rationale for Modeling Dunlap and Jones’s Framework
One key similarity between environmental and biotech concern is the ambiguity
of the subject matter. The environment is a particularly elusive concept, which Heberlein
(1981) contributes to the multiple sub-objects that represent the environment in its
entirety. Likewise, biotechnology has several dimensions that can be delineated by a
variety of factors (e.g. variation in processes, products, or impacts). Variation can be real
or perceived, and it is from this diversity in perspectives that concern results (see Denzin
1989). Because of the plurality of perspectives, Jones (1993) has argued that it is
impossible to develop a universally accepted definition of biotechnology. Although a
clear definition is not necessary for the study of biotechnology (see Heberlein 1981),
formalization would minimize this ambiguity (see Shye, Elizur and Hoffman 1994).
Like US studies on biotech concern, many of the early studies on environmental
concern were ad hoc, atheoretical, and noncumulative; for environmental concern studies,
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Table 4.1 Descriptions of Study and Number of Questions Included
Source
Year
Title of Report
Conducted

Number of
Questions
(n=569)
15

American Broadcasting
Corporation

2003

Modified Foods Give Consumers Pause

Gallup Poll

2001

Biotech Food Remains Fairly Obscure to most
Americans

20

Gallup Poll

2005

Britons Show Distaste for Biotech Foods

3

General Social Survey

2011

General Social Surveys: 1972-2010

18

Harris Poll No. 33

2000

Genetically Modified Foods: An Issue Waiting
to Explode?

8

Harris Poll No. 35

1993

Jurassic Park Prompts the Thought that the
Risks of Genetic Engineering Outweigh the
Benefits

3

International Food
Information Council (IFIC)

2010

Consumer Perceptions of Food Technology
Survey

45

IFIC

2006-2008

Food Biotechnology: A Study of US Consumer
Trends

35, 41, 40

IFIC

2001

61

Harris Interactive and the
Chicago Council on Foreign
Relations

2002

US Consumer Attitudes Toward Food
Biotechnology
American Public Opinion and US Foreign
Policy

International Social Survey
Program

2000

Environment II

1

Inter-University Consortium
for Political and Social
Research (ICPSR) No. 3030

1997

United States Biotechnology Study

105

ICPSR No. 2874

1999

CBS News “CBS.Marketwatch.com Millennium
Poll

1

ICPSR No. 6952

1993

Comparison of Risk Attitudes and Perceptions
in Japan and the United States, 1993

2

Lake Research Partners

2010

Attitudes toward the FDA’s Plan on Genetically
Engineered Fish

2

National Public Radio (NPR)

2000

NPR/Kaiser/Kennedy School Technology
Survey

2

Pew Initiative on Food and
Biotechnology

2001

Public Sentiment About Genetically Modified
Food

41

42

3

Table 4.1 Descriptions of Study and Number of Questions Included Continued
Source
Year
Title of Report
Conducted

Number of
Questions
(n=569)
55

Pew Initiative on Food and
Biotechnology

2003

An Update on Public Sentiment About
Agricultural Biotechnology

Pew Initiative on Food and
Biotechnology

2004

US Consumer Opinion Divided: Overview of
2004 Findings

62

Thomas Reuters and NPR

2010

National Survey of Healthcare Consumers:
Genetically Engineered Food

7

43

this has been contributed to the ambiguity of the subject matter (see Dunlap and Jones
2002). Many of the early environmental concern studies focused on only one or a few of
the sub-objects (see Heberlein 1981), and a wide range of measures were used (Dunlap
and Jones 2002). The result was a disorganized and incoherent literature (see Heberlein
1981). As discussed in chapter one, there is no scholarly consensus on the definition of
biotechnology, and a wide array of conceptualizations and measurements has been used
in studying biotech concern; likewise, this has thwarted the evolution of a well-developed
literature.
Applying Dunlap and Jones’s Framework to Biotech Concern
The framework suggested by Dunlap and Jones (2002) was designed to address
the complexity inherent in understanding environmental concern, and because of this, it
addresses the multiple dimensionality of biotech concern especially well. Dunlap and
Jones (2002) state that there are basically two components in the conceptualization of
environmental concern: the environmental and concern component. They refer to these
as the substantive and theoretical components, respectively. To transform their
framework into that for the study of biotech concern, I used a variant of their
environmental component but mostly retained their use of the concern component.
To clarify the meaning of environmental concern, Dunlap and Jones (2002) draw
from facet theory. Facet theory integrates content design with data analysis (Shye, Elizur
and Hoffman 1994) and is mainly used in the construction of systems for documentary
classification schemes (Broughton and Slavic 2007). Facet theory provides guidance for
mapping the conceptual space and empirical boundaries of research domains and for
decomposing complex concepts into their key facets (Dunlap and Jones 2002:485).
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According to Guttman, the founder of facet theory, and Greenbaum (1998), a facet is a
set of attributes that together represent the underlying conceptual and semantic
components of a particular research object. Facet theory offers a classification scheme
that captures the “universe of environmental concern.” Concerning the environmental
component, the universe encompasses the major dimensions that represent the object of
concern; for concern, the universe is composed of forms of expression drawn from
attitude theory (Dunlap and Jones 2002). Because facet theory is systematic and explicit,
it facilitates the measurement of complex concepts such as biotech concern.
The concern component. The concern component draws from attitude theory and
represents both the expression and operationalization of environmental/biotech concern.
In the literature on attitude theory, attitudes are largely used synonymously with concern
(Ester 1981), and it is generally agreed that they consist of both cognitions and affects
(Heberlein 1981). The cognitive component is usually treated as beliefs and knowledge
about the object of study, while the affect component involves an emotive and evaluative
aspect (Dunlap and Jones 2002). Dunlap and Jones (2002) use a scale developed by
Maloney and Ward (1973) to operationalize the concern component.
Maloney and Ward (1973) measure cognition as a function of the knowledge one
has about the object of study and affect as the degree of emotionality or one’s attitude
toward the object. Because behavior is often treated as an indicator of concern, Dunlap
and Jones (2002) also included two measures of behavior in their scale. Verbal
commitment measures what a person states he or she is willing to do, and actual
commitment measures what a person self-reports as having done. Overall, Dunlap and
Jones (2002) advocate for the use of four measures to get at concern: knowledge,
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attitudes, conative behavior (i.e. verbal commitment), and actual behavior. For the
purposes of my study, I differentiated objective knowledge from knowledge claims and
created two separate measures, knowledge and belief, respectively. This resulted in five
dimensions to the concern component in my framework: attitudes, conative behaviors,
actual behaviors, beliefs, and knowledge.
Some examples may clarify the differences between the dimensions. Attitudinal
questions may ask respondents to indicate their level of support for biotechnology on a
Likert scale. Questions that ask respondents about the likelihood of purchasing biotech
food products would be understood as asking for a verbal commitment. This is distinct
from actual behaviors, which would include questions about past purchasing behavior. A
question about beliefs may ask the respondents if they think biotechnology in food
production will help mitigate the effects of climate change. This differs from knowledge
questions, which may ask respondents if food products produced using biotechnology are
available in markets now.
The environment/biotech component. Several of the facets that Dunlap and Jones
identified in their study of the environmental component are applicable to the biotech
component in biotech concern. The spatial facet distinguishes between geographical
scales, such as local, national, and global levels (Dunlap and Jones 2002). For example, a
question centered at the local level may ask about the availability of biotech products at
the grocery store. The temporal facet distinguishes between the past, present, and future
(Dunlap, Gallup Jr. and Gallup 1993). So, a question centered in the present may ask
about the FDA’s current regulations. Dunlap and Jones (2002) also delineate a specificity
facet, which discerns concern ranging from very general to very specific. Questions may
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be as general as, “Do you feel that biotechnology will provide benefits for you or your
family?” (IFIC 2001), or they may elicit very specific details about the expected benefits.
The biotech component also has a content-specific facet, which contains those
dimensions that comprise the fundamental features of biotechnology. This facet could
not be borrowed from Dunlap and Jones, so to construct one specific to biotechnology I
engaged in sentence mapping.
Sentence mapping is a technique employed in facet theory that is used to express
observations in an explicit and systematic way. To begin, three areas must be defined:
the focus, sense, and image. Together the focus and sense comprise the domain and the
image is referred to as the range. The domain consists of the essential features of the
object of study and the range depicts all acceptable responses to the questions regarding
the object of study (Shye, Elizur and Hoffman 1994). The domain and range for the
content-specific facet are depicted in Table 4.2.
To determine the range, I conducted a content analysis of the questions in the
questionnaires. Content analysis is essentially a coding operation (Babbie 2004). Codes
are the basis for operationalizing the biotech component and represent the attributes that
comprise biotechnology; because these attributes should be mutually exclusive and
exhaustive, developing them was an onerous task. Using the questions in the
questionnaires as the unit of analysis, the object or objects of inquiry in each question
was coded and used in the construction of the range. The codes were also developed in
conjunction with the major classifications and divisions expressed in the literature on
biotechnology. Table 4.3 depicts all the codes or dimensions developed for biotech
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Table 4.2 The Domain and Rage of Content Specific to Biotechnology
Focus
Sense
Image
Concern
Greater
Food
Less
Crops
Animal Use
Medical Use
Human Health
Environmental Health
Regulation
Labeling
Economics
Cloning
Pesticide Use
Human Hunger
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concern as well as a brief description of each. For a more in-depth description of each
code, see Appendix C.
After identifying the domain and range, a mapping definition was developed. A
mapping definition provides a formal definitional framework that aids in hypothesis
formation and testing (Guttman and Greenbaum 1998). Mapping definitions aid in
distinguishing the elements of the object of study as well as possible interrelations
between the elements, all of which is necessary to engage in sentence mapping. This
includes the formal parts made up by the dimensions and the less formal parts made up
by the phrases that link the dimensions together (Guttman and Greenbaum 1998). All
possible sentence maps, which comprise the mapping definition of biotech concern, are
depicted in Table 4.4.
Note Facet A. Since 1991 the European Union has used a split ballot to document
the variation in reported concern based on the terminology used to depict the technology
(European Commission 2010). To test if this variation is applicable to the United States,
I introduced a linguistic facet. This facet, along with those belonging to the theoretical
and substantive components, makes up the universe of biotech concern.
ORGANIZATION OF DATA
In my study, the questions in the questionnaires are my unit of analysis. Not all
questions in the 22 questionnaires were included in my study. If the questionnaire
focused specifically on biotechnology, all questions, except those on demographic
characteristics, were included. However, if the main thrust of the questionnaire was on
something other than biotechnology (e.g. technology in general), only those questions
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Table	
  4.3	
  Descriptions	
  of	
  Dimensions	
  	
  
Component
Facet
Sub-object
Biotechnology ContentBiotech Food
Specific
Biotech Crops
Animal Biotechnology
Biotech Crops and Animals
Medical Biotechnology
Human Health
Environmental Health
Regulations
Labeling
Economics
Cloning
Pesticide Use
Human Hunger
Spatial
Local Level
National Level
Global Level
Temporal
Past
Present
Future
Linguistic
Biotechnology
Genetic Modification
Genetic Engineering
Genetic Alteration
Concern
Theoretical
Belief
Knowledge
Affect
Conative Behavior
Actual Behavior
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Description
Generally refers only to food
Refers to crop production
Refers to animal use
Specifies crops and animal
Refers to medical use
Health, excluding medical
Refers to biophysical aspects
Refers to government action
Refers to any labeling issue
Refers to market values
References use of cloning
Refers to pesticide use
Refers to reducing hunger
Centered at local level
Centered at national level
Centered at global level
Concerned with past
Concerned with present
Concerned with future
States term or derivative
States term or derivative
States term or derivative
States term or derivative
Refers to awareness
Refers to the objective
Concerned with emotions
Refers to intentions
Concerned with self-reports

Table 4.4 Sentence Map: The degree of concern expressed about...
Facet A: Linguistic
Facet B: Theoretical
{1. Biotechnology}
{2. Genetic Modification}
{3. Genetic Engineering}
{4. Genetic Alteration}

varies as an
expression
of

Facet C: Spatial
{1. Local}
{2. National}
{3. Global}

{1. Belief}
{2. Knowledge}
{3. Affect}
{4. Conative Behavior}
{5. Actual Behavior}

and as to whether
the scope is

Facet D: Temporal
and the
temporal
reference is

{1. Past}
{2. Present}
{3. Future}

Facet E: Content-Specific
{1. Food}
{2. Crops}
{3. Animal Use}
{4. Crops and Animal Use}
{5. Medical Use}
{6. Human Health}
{7. Environmental Health}
{8. Regulation}
{9. Labeling}
{10. Economics}
{11. Cloning}
{12. Pesticide Use}
{13. Human Hunger}
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for questions
about

pertaining to biotechnology were included. This resulted in the inclusion of 569
questions, each of which is listed by source in Appendix D.
After collecting the questionnaires, I compiled information about the sources, the
questions posed, and the responses reported into a Microsoft Excel spreadsheet. Each
question was assigned an identification number and a source-identification number. The
year the study was conducted, the number of respondents, and the exact wording of each
question were recorded. Codes were developed for the various collection methods:
telephone, web, in-person interview, written survey, or mixed methods. The only study
that used mixed methods was the 2002 American Public Opinion and US Foreign Policy;
telephone and in-person interviews were employed. I also coded whether the question
was asked to the full sample or a subsample, and each question was coded according to
its type of measurement: dichotomous, trichotomous, scale, open-ended, multiple-choice,
Likert, or Likert-type choices. Likert-type questions indicate levels of agreement
similarly to Likert questions, but do not have the traditional seven levels. Each question
was then coded to depict the type of response elicited (e.g. degree of favorability, level of
support, amount of knowledge). See Table 4.5 for a list and examples of questions and
response types. For more information on the codes developed, refer to the codebook in
Appendix E.
The responses to each question were also recorded. Recording the plethora of
response patterns afforded by the various questions was problematic in Excel. The
following strategy was employed to alleviate the problems associated with using such a
simple interface. Each question had a code for the number of responses possible,
excluding “don’t know.” The next cell displayed the percent of participants that
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Table 4.5 Examples for Question and Response Types
Type
Description
Example
Question Type Likert or Liker-Type
Indicate level of Agreement: I would buy genetically modified
food if it was nutritionally enhanced.

Response Type

Dichotomous

Are biotech foods currently available in your grocery store?

Trichotomous

Indicate if the following statement has a positive, a negative or
no effect on your opinion of biotechnology: biotechnology can
increase farm efficiency.

Open Ended

What, if anything, are you concerned about when it comes to
human consumption?

Ranked

Rank the following factors in order of importance to you:
producing plants that require less water, petro inputs, tilling.

Multiple Choice

Which of the following benefits, if any, do you expect to
receive from biotechnology within the next five years?

Scale

On a scale of one to ten, with one being uncomfortable and ten
being confortable, how comfortable are you with
biotechnology?

Degree of Confidence

How confident are you that the food we eat in the United States
is safe?

Safe or Not

Do you think genetically modified food is safe to eat?

Yes or No

Do you feel that biotechnology will provide benefits for you
and your family within the next five years?

Likelihood of
Phenomena

If cooking oil with reduced fat was produced via biotechnology,
how likely would you be to buy it?

Should or Should Not

Do you think Europe should be able to require the labeling of
products that contain biotech ingredients?

Amount of
Information Obtained

How much would you say you have heard about
biotechnology?

Degree of Favorability

What is your overall impression of genetically modified foods?

Positive or Negative
Reaction to Statement

Does the following statement have a positive, a negative or no
effect on your impression of biotechnology?

Degree of Importance

How important is it to you that you purchase GMO-free food
products?

Degree of Danger

How dangerous for the environment is modifying the genes of
certain crops?

Greater Risk or
Greater Benefit

Do you think the benefits outweigh the risks in biotechnology?
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Table 4.5 Examples for Question and Response Types Continued
Type
Description	
  
Example
Level of
On a scale of one to five, how well do you understand
Understanding
biotechnology?
Level of Agreement

Please indicate your level of agreement: biotechnology is
morally acceptable.

Level of Trust

How much trust do you have in the FDA’s regulations for
biotechnology?

Support or Oppose

Do you support or oppose the use of biotechnology is
agricultural production?

Inheritance or
Environmental

Is happiness hereditary or environmentally induced?

Understand or Not

Do you understand the basic process involved in agricultural
biotechnology?

True or False

True or false: biotechnology results in the creation of novel
genes?

Frequency of Event

How often have you had conversations about biotechnology in
the last few months?

Right or Wrong

Do you think it is right or wrong to use scientific techniques to
enhance flavors?

Degree of Influence

How influential would a statement from the following sources
be in assuring you the safety in biotech food production?

Level of
Responsibility

How much responsibility do you have for your household
shopping decisions?

Same as Conventional
or Not

Is there a difference in safety between consuming GM or nonGM corn?

Degree of Concern,
Confidence, or Worry

Indicate your level of comfort with genetically modifying
plants.

Favor or Oppose

Do you favor or oppose scientific research into genetic
modification?

Good or Bad

Do you think modifying plants to reduce the need for pesticides is
good or bad?

Missing: Open-ended
or Multiple Choice

What would you like to see labeled that currently is not?
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responded with “don’t know” and the following 11 cells displayed the percentage of
respondents that identified with each response. The percentages within each cell
corresponded to the response pattern explicated in the questions. For example, a question
centered on the level of support would result in the first cell depicting the percentage of
respondents that reported the greatest level of support with the last cell depicting the
lowest level of support. Not all questions had 11 response options. To distinguish the
valueless cells from missing data, two separate codes were developed. Only valid
responses, if they could be distinguished, were included, meaning “refusal to respond”
were omitted.
To operationalize biotech concern, each question was coded according to the
substantive and theoretical facets expanded upon above. Each dimension, or variable,
within the facets were dummy coded with a one if it was expressed in the question and a
zero if it was not expressed. To increase reliability, each variable was assigned key
words to flag questions for the appropriate coding. Using the IF, SUM, and COUNTIF
formulas, I wrote a function that coded questions according to my coding scheme. See
Appendix F for a list of key words by dimension and a more detailed description of my
Excel function. Along with coding for explicit content, I also coded underlying meaning
in the questions. For example, a question may ask for the respondent’s level of support
for the FDA’s labeling practices, and although not explicitly stated, this question refers to
current labeling practices and would be coded as such. To code for this latent content, as
well as to check the coding accuracy of my formula, all 569 questions were scrutinized
multiple times.
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DESCRIPTION OF DATA
This section examines information about the data source, the questions, and the
responses, as well as provides a description of the dimensions for each facet of biotech
concern. To calculate the following statistics, the Excel dataset was converted to a .dta
file and used in Stata 11.
Examining the Sources
Table 4.6 displays the various information recorded about the sources of the
questionnaires. The dates the questionnaires were administered ranged from 1993 to
2010, with 2003 as the mean. The average number of respondents is 1,068 per
questionnaire, which is reasonable considering all questionnaires were nationally
representative. The bulk of the questionnaires (67.1 percent) were conducted via
telephone, followed by web-based (29.0 percent). This is consistent with the shift in
popularity to web-based surveys in the mid-2000s (see Giesler 2012).
There was some consistency between the type of question asked and the type of
response elicited. This is illustrated in Table 4.7, which depicts percentages for the
question types by select response types. Most of the questions (60.1 percent) were either
a Likert or Liker-type question, which provoked the greatest range of response types.
Most of these questions asked about the likelihood of a phenomenon (24.3 percent) or for
a level of agreement (11.7 percent); other common response types asked about the degree
of favorability towards (9.7 percent), trust in (9.7 percent), and goodness of (8.5 percent)
various issues about the dimensions. Slightly over 21 percent of the questions were
dichotomous. Of those, over half (51.2 percent) elicited a “yes or no” and nearly a fifth
(17.4 percent) elicited a “true or false.” There was no marked variation between ranked
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Table 4.6 Descriptive Statistics of Source Information
Information
Mean or Proportion
Year Conducted
2002.91 (SD 4.29)
Number of Respondents
1068.27 (SD 607.95)
Method
Telephone Interview
67.10
In-person Interview
3.30
Web-based Interview
29.00
Mixed
.40
Written Questionnaire
.20
Questions Asked to Full Sample
80.5
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Table 4.7 Percentages for Question Types by Select Response Types
Question
Degree of Concern, Degree of
Likelihood of Level of
Type
Comfort, or Worry
Importance Phenomena
Agreement
Dichotomous 0
0
9.09
Likert or
2.63
2.34
24.27
11.70
Likert-Like
Multiple0
0
0
0
Choice
Open-Ended
0
0
0
0
Ranked
0
100.00
0
0
Scaled
85.71
7.14
0
0
Trichotomous 0
0
0
0
n=569
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Reaction to
Statement
0
0

All
Types
21.30
60.10

0

3.00

0
0
0
80.00

6.70
3.9
2.5
2.6

questions and response type; all examined the degree of importance over issues for a
particular dimension. Scaled and trichotomous questions exhibited a similar pattern.
Most scaled (85.7 percent) questions asked about the degree of concern, comfort, or
worry over a dimension, and most trichotomous (80.0 percent) questions asked for a
reaction to a particular statement. The multiple-choice and open-ended questions did not
have a standardized response, and since they constituted less than seven percent of the
sample, I recoded the response type as missing (See Note 1).
Examining the Dimensions of Biotech Concern
Table 4.8 provides descriptive statistics for each dimension that comprise the
universe of biotech concern. Recall the first three facets comprise the biotech
component, the fourth the concern component, and that the linguistic facet was added to
examine if concern expressed varied by the terminology used to depict biotechnology.
The linguistic and the content-specific facets contain variables that are not mutually
exclusive; that is, questions can identify with multiple variables in each facet. However,
the spatial, temporal, and theoretical facets contain mutually exclusive variables.
Biotech Food, Crops, and Animals. A third of the questions inquired about
biotech food in the most general context. That is, no attributes were given to distinguish
between types of biotech food. These questions examined biotech food on the most basic
level and do not account for variation in response to more specific aspects (e.g. use with
crops or animals). However, even fewer questions distinguished between use with crops
(17.2 percent) and animals (13.4 percent). About seven percent were double-barreled
questions that asked about use with both animals and crops.
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Table 4.8 Descriptive Statistics for the Dimensions of Biotech Concern
Content-Specific Facet
Mean or Proportion
Biotech Food
.33
Biotech Crops
.17
Biotech Animals
.13
Biotech Animal and Crops
.07
Medical Aspect
.12
Human Health
.23
Environmental Aspect
.08
Regulation
.15
Labeling
.07
Economic Aspect
.22
Cloning
.03
Pesticide Use
.04
Human Hunger
.02
Other
.34
Spatial Facet
Local
.31
National
.09
Global
.02
Not Specified
.57
Temporal Facet
Past
.14
Present
.70
Future
.16
Theoretical Facet
Belief
.42
Attitude
.14
Conative Behavior
.14
Actual Behavior
.22
Knowledge
.07
Linguistic Facet
Biotechnology
.47
Genetic Alteration
.01
Genetic Engineering
.08
Genetic Modification
.31

60

Medicinal Biotechnology. Over a tenth (11.8 percent) of the questions asked
about the use of biotechnology for medicinal purposes. This included both questions
about medicinal use with crops and animals. The small percentage of questions about the
wide range of medicinal uses may be due to medical use being less controversial than use
with food; prior research has indicated that public concern about the use of biotechnology
for medical purposes is not as great as concern for food production (see Asian
Development Bank 2001;Qaim 2009; Stone 2010).
Human and Environmental Health. Concern about the relationship between the
consumption of biotech products and human health is salient in nearly a fourth of the
questions (23.0 percent). Next to biotech food, this is the dimension most inquired about.
According to Reilly (2000), many other studies have found human health issues to be at
the forefront of biotech concern. Concern over human health sharply contrasts with
concern over environmental health. Concerns about the effects of releasing biotech
organisms into the environment are inquired about in less than a tenth (8.4 percent) of
questions. This indicates that there is a greater focus on studying human health concerns
than environmental health concerns.
Biotech Regulations and Labeling. Regulation is the fourth most inquired about
dimension. About 15 percent of the questions focused on regulation, and 49 percent of
these asked about labeling issues. This is not surprising as labeling is the most complex
and contentious issue for biotech politics today (Hoban 2004); this is largely because
mandatory labeling is a well-accepted idea that has not been implemented (see Shanahan,
Scheufele, and Lee 2001). In my study, the demand for labeling varied widely according
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to the wording of the question. For example, the Internal Food Information Council
(IFIC) (2010:4) asked,
“The U.S. Food and Drug Administration (FDA) requires special labeling
when a food is produced under certain conditions: when biotechnology's
use introduces an allergen or when it substantially changes the food's
nutritional content, like vitamins or fat, or its composition. Otherwise
special labeling is not required. Would you say that you strongly support,
somewhat support, neither support nor oppose, somewhat oppose or
strongly oppose this policy of FDA?”
This question mentioned only supporting arguments for the FDA’s labeling policy
(Shanahan, Scheufele, and Lee 2001), and only 12 percent of respondents expressed
opposition (IFIC 2010). However, when asked straightforward questions about
mandatory labeling, most respondents express support. For example, a 2010 study by
NPR and Thomas Reuters reported that 93 percent of respondents supported labeling
when asked, “Do you believe that foods should be labeled to indicate that they have been
genetically engineered or contain ingredients that have been genetically engineered?”
Other studies have reported similar findings (American Broadcasting Corporation 2003;
Miller 1998; Pew Initiative on Food and Biotechnology 2004; Taylor 2000).
Biotechnology and Economics. A little less than a quarter (22.1 percent) of the
questions were over the economic dimension of biotechnology. Although there were a
variety of issues inquired about under the umbrella of economics, nearly half (49.2
percent) were centered at the local level and most asked about purchasing behavior.
According to a meta-analysis conducted by Lusk and colleagues (2005), 26 percent of US
consumers report a willingness to pay more for non-biotech foods; this is consistent with
the findings in this study. Four questions (2.4 percent) asked about global policy issues;
of these, all asked about EU policies (Harris Interactive and the Council on Foreign
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Relations 2002; Pew Initiative on Food and Biotechnology 2003). Other topics include
attitudes towards and knowledge of certain products.
Cloning. Only 2.8 percent of questions inquired about cloning. The small
number of questions asking about cloning is not surprising. Public concern for cloning
has primarily been over use with humans, and accordingly, US policy bans the use of
federal funds to create or experiment with human embryos. Of the 16 questions included
in this study that do ask, most (75.0 percent) asked for general impressions or willingness
to purchase cloned meat products.
Biotechnology Pesticide Use and Human Hunger. Decreasing pesticide use and
alleviating human hunger are often touted as benefits from adopting biotechnology (see
Herdt 2006; Food and Water Watch 2011). Despite this, only four percent of questions
asked about biotechnology in relation to pesticide use, and two percent in relation to
mitigating human hunger. This is curious, as both dimensions are salient and widely
contested. The majority (62.5 percent) of the questions about pesticide use were from the
IFIC and asked about the likelihood of purchasing a product bioengineered to reduce the
need for pesticides or to rank the importance of reducing use in sustainable farming. The
questions about mitigating hunger only asked about increasing yields to produce less
expensive foods, reducing the need for converting valuable land to farmland, or feeding a
growing population.
Spatial and Temporal Dimensions. The majority of the questions in this study
were primarily centered at the present moment (69.9 percent) and the spatial facet was
unspecified (56.8 percent). However, both of these numbers may be inflated. If a
question did not specify if it was concerned with the past, present, or future, it was
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assumed to be concerned with the present moment. Slightly over 13 percent of the
questions were centered in the past, of which the vast majority (96.3 percent) asked about
past behaviors. Likewise, if a question did not specify if it was concerned with a local,
national, or global biotech issues, it was coded as unspecified. Nearly the remainder
(30.0 percent) of the questions was centered at the local level.
Theoretical Dimensions. Attitudes are evaluative or emotive. For the first decade
of studying US biotech concern, much of the research indicated that the public generally
reported positive attitudes about biotechnology (Hoban 1997). However, negative
attitudes are becoming more prevalent over time (Shanahan, Scheufele, and Lee 2001).
Much of the data in this study exemplifies this claim. For example, over time the IFIC
has posed the question, “Do you feel that biotechnology will provide benefits for you and
your family within the next five years?” In 1999, 79 percent of respondents reported yes,
but in 2010 only 32 percent of respondents reported yes. Only 14.2 percent of the
questions in this study measured attitudes.
The two behavioral measures included conative and actual behaviors. Over a
tenth (12.8 percent) of the questions asked about conative behavior. Of these, nearly half
(56.2 percent) asked about the likelihood to purchase a biotech product. Most assumed a
similar form to this IFIC question, “All things being equal, how likely would you be to
buy a variety of produce, like tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher?” In 1997, 55 percent of respondents indicated
that they were likely to purchase the product, but when asked the same question in 2010,
reported likelihood declined by 12 percent. Nearly twice as many (22. 0 percent) of the
questions asked about actual behavior. Of these, the issues asked about were quite
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diverse. The most common (31.2 percent) asked respondents for the amount of
information they have heard, read, or otherwise obtained about biotechnology. At the
turn of the twenty-first century, around 50 percent of the public reported having obtained
some information about biotechnology (see Gallup 2001; IFIC 2001; Pew Initiative on
Food and Biotechnology; Taylor 2000), but shortly after, that percentage dropped by
about 10 percent (see IFIC 2006; Pew Initiative on Food and Biotechnology 2004).
Beliefs and knowledge are often viewed as two points on a continuum and can be
jointly understood as awareness. Much of the data in this study indicates that public
awareness has declined. For example, in 1997 and again in 2010, the IFIC asked
respondents, “As far as you know, are there any foods produced through biotechnology in
the supermarket now?” In 1997, 68 percent of respondents reported yes, but only 28
percent responded yes in 2010. Interestingly though, US residents seem to be more
aware of their lack of awareness (Hoban 2004). Considering the previous example, in
1997 only 23 percent of respondents reported that they did not know if there were biotech
products available in the supermarket. However, by 2010 that number had rose to 64
percent. Despite US residents increasingly self-reporting less awareness, they still tend to
report strong attitudes for a variety of biotech issues (see Legge Jr. and Durant 2010).
Linguistic Dimensions. Across measures, nearly half (45.3 percent) of the
questions used the term biotechnology, and over a third (30.9 percent) used genetic
modification. The Eurobarometer, through the use of a split-ballet, has shown the
amount of concern expressed across the dimensions to differ according to the
terminology used to depict biotechnology (e.g. genetic engineering, modification, or
alteration: European Commission 2010). Previous research has indicated that like EU
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members, the US public is much more accepting of biotechnology than genetic
engineering (see Hoban 2004). Unfortunately, few of the questionnaires I collect used a
split-ballet to measure if concern differed according to the terminology depicted. This
issue is addressed in the next chapter.
Specificity Facet. Upon examining an individual question, it is difficult to gage
the question’s specificity. I struggled to understand how to measure a question’s
specificity and decided to measure it by the number of dimensions it expressed. This is
why this facet is not included in the mapping definition for biotech concern. Figure 4
displays the distribution of questions by specificity across time. As can be seen by this
distribution, the bulk of questions were neither very general nor very specific. However,
the distribution was slightly skewed towards more general questions.
In sum, this chapter described the collection and organization of the data I
collected, the development of my framework, and its application to the 22 questionnaires
collected. The intent of this study was to generate findings not specific to a particular
study, and the criteria used to select the questionnaires included were developed to foster
more generalizable results. In conjunction with the literature review, the questionnaires
were used to help identify the dimensions of US biotech concern and develop my
framework. The framework I developed was then applied to the questionnaires to
demonstrate its use in summarizing the otherwise fragmented findings reported in the
individual studies.
NOTES
1

Although the response type for multiple choice and open-ended questions was recorded

as missing, the actual responses (i.e. the percentage of respondents that identified with
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each response option) were recorded, if possible. The actual responses for all multiplechoice questions were recorded, and if response patterns for the open-ended questions
were developed post hoc and reported, they were also recorded.
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CHAPTER V
ANALYZING PUBLIC CONCERN
In this chapter, I analyze the ways in which the various aspects of questions asked
in the questionnaires are related to the percent of US residents that express concern over
biotechnology. If couching biotech concern within the larger literature on environmental
concern, it seems logical that reported concern will vary by the dimension(s) of biotech
concern being tapped into by the question; previous research has found that concern
expressed over environmental issues varies according to the different aspects of
environmental concern being inquired about (see Dunlap and Jones 2002; Klineberg,
McKeever, and Rothenbach 1998). The literature on environmental concern has also
shown concern to vary over time (Dunlap and Jones 2002; Dunlap and Scarce 1991),
which is a trend I expect to find in US concern expressed over biotechnology.
In the literature review I conducted on US biotech concern, several studies
indicate that concern varies by dimension. For example, more concern has been shown to
be expressed about red, rather than green, biotechnology (see Asian Development Bank
2001; Qaim 2009; Stone 2010). Labeling has been identified as an especially contentious
issue (Shananan, Scheufele, and Lee 2001). Less concern has been shown to be
expressed over questions using the term biotechnology instead of the terms genetic
engineering or modification (Haban 2004). The literature review on US biotech concern
discussed in greater detail in chapters two and three, as well as the greater literature on
environmental concern, informed the following six hypotheses tested in this analysis:
Hypothesis 1: The percent of US concern reported has varied over time.
Hypothesis 2: The percent of US concern reported varies by the content-specific
dimension of biotech concern measured in survey questions.
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Hypothesis 3: The percent of US concern reported varies by the spatial dimension
of biotech concern measured in survey questions.
Hypothesis 4: The percent of US concern reported varies by the temporal
dimension of biotech concern measured in survey questions.
Hypothesis 5: The percent of US concern reported varies by the theoretical
dimension of biotech concern measured in survey questions.
Hypothesis 6: The percent of US concern reported varies by the linguistic
dimension of biotech concern measured in survey questions.
To test these hypotheses, only questions determined to be an indicator of concern were
included in this analysis. Not all the questions included in the dataset could be taken as
an indicator of concern. For example, Thomson Reuters and NPR (2010) asked, “On a
scale of one to five, how well do you understand genetically engineered foods?” This
question was not determined to not be an indicator of concern, nor was the following
question, taken from a 2001 survey by the Pew Initiative on Food and Biotechnology:
“How much would you say that you know about government regulation of genetically
modified food?” Determining what indicated concern was largely subjective and I relied
on a standard of face validity.
What constituted the percent of concern varied according to the type of response
elicited by the questions. For Likert-type questions, any response greater than the
midpoint was defined as concern. Concern for dichotomous questions was simple to
discern because it typically entailed responses like “agree or disagree,” “yes or no,” and
“should encourage or should not encourage.” Concern for trichotomous questions was
also simple to discern because its format was similar to dichotomous questions, but
typically included a “don’t know” or “unsure” response category, which were interpreted
to mean that an overt indicator of concern was not expressed. Open-ended questions
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were excluded from the analysis. Ranked questions were also excluded from the analysis
because none were determined to be indicators of concern, and only one scaled question
was determined to be an indicator of concern and was included.
Overall, the sample size was reduced from 569 cases to 269. Only 37.2 percent of
the dichotomous, 58.8 percent of Likert or Likert-type, 47.1 percent of multiple choice,
93.3 percent of the trichotomous, and 7.1 percent of scaled questions were included. All
knowledge questions were omitted because none were taken to indicate concern; almost
all (81.5 percent) of the attitudinal questions were included, as well as about half (47.7
percent) of the questions about beliefs and 40.2 percent of behavioral questions. For
example, the attitudinal question, “Do you feel biotechnology will provide benefits for
you or your family in the next five years?” (IFIC 1999), was not taken as an indicator of
concern; it is possible respondents could not be concerned about biotechnology but still
not expect benefits. Table 5.1 provides the descriptive statistics for the various aspects of
biotechnology, including only the questions determined to indicate concern.
It is important to note that some variables had to be combined to provide adequate
statistical power. If the variables constituted less than 10 percent of the sample, they
were combined in the catchall variable other. This included the environmental health,
labeling, cloning, pesticide use, and human hunger variables. The other category
included topics such as nanotechnology and sustainability. As for the spatial dimension,
the national and global levels were collapsed to create a national/global variable. The
past and present variables were combined to create a present/past variable, the conative
and actual behavior variables were combined into one behavioral variable, and genetic
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Table 5.1 Descriptive Statistics for Indicators of Concern, by Dimension
Dependent Variable
Mean or Proportion
Concern Expressed
34.35 (SD 22.46)
Content-Specific Dimensions of Concern
Frequency
Biotech Food
.29
Biotech Crops
.21
Animals and Crops
.12
Animal Aspect
.20
Medical Aspect
.12
Human Health
.35
Regulations
.19
Economics
.28
Other
.33
Year Survey Conducted
2003.41 (SD 4.08)
Spatial Dimensions of Concern
Local Level
.25
National/Global Level
.12
Level Not Specified
.63
Temporal Dimensions of Concern
Future
.23
Present/Past
.77
Theoretical Dimensions of Concern
Belief
.42
Attitude
.25
Behavior
.30
Linguistic Dimensions of Concern
Biotechnology
.48
Genetic
.33
n= 269
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modification, genetic engineering, and genetic alteration were combined to create a
generic genetic variable.
From table 5.1, it can be seen that on average, 34.35 percent of respondents
reported concern across all questions, regardless of dimension. However the standard
deviation is quite large (22.46), which indicates that when asked some questions,
respondents expressed much concern and when other questions were asked, respondents
expressed little concern. As for the content-specific dimension, human health issues were
the most common aspect asked about (35.3 percent) among the survey questions deemed
to indicate concern over biotechnology. This was followed by biotech food issues in
general (29.4 percent), economic issues (27.5 percent), and issues involving use with
animals (20.1 percent). Most questions (63.2 percent) did not specify a spatial dimension
or were centered at the local level (24.91 percent), which indicates that most
questionnaire designers were not interested in global biotech issues. About a quarter of
the questions were centered on future issues (22.7 percent), with the majority of the
questions (77.3 percent) centered on past or present issues. As for the theoretical
dimension, most of the questions (42.0 percent) were aimed at respondents’ beliefs,
followed by behaviors (29.7 percent,) and attitudes (24.5 percent). Lastly, the terms
biotechnology and genetic modification, engineering, or alteration show up in the
questions pretty evenly. Biotechnology shows up in 48.3 percent of the questions, and
genetic modification, engineering, and alteration shows up in 33.1 percent of the
questions.
The Model
To test the six hypotheses, OLS regression models were developed. Each model
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was tested to ensure that Gauss-Markov assumptions were met. One potential source of
error in this analysis derives from the fact that each case of the dependent variable
represents a point estimate, and each questionnaire's point estimates have a different
amount of error due to differing sample sizes and sampling approaches. This variability
introduces a potential violation of the Gauss-Markov assumption of identical
variance. (In the case of the models presented in this chapter, this violation is confirmed
by the results of a Cook-Weisberg test.) This difficulty is compounded by the fact that
point estimates taken from subsamples (i.e. some cases of my dependent variable) can
have even greater error than those taken from complete samples. The concern is that
those respondents to the survey not included in the subsample represent missing data, and
these missing data are a potential source of additional bias. Measures of concern taken
from subsamples that are randomly drawn from the larger sample are not problematic,
since those not in the subsamples are assumed to be missing completely at random
(MCAR). They do not add additional error to the model. Measures of concern taken
from subsamples in which respondents were asked questions or not depending on
answers to previous questions creates conditions in which the missing data (those not
asked the question) are missing not at random (MNAR). The MNAR condition adds
error to the model.
There are three possible means of dealing with the non-identical error
problem. One means to attempt to reduce error is to exclude cases from the model if data
are taken from MNAR subsamples. This approach removes point estimates (i.e. cases of
the dependent variable) with greater error. Unfortunately, removing these cases also
increases error in the models I would ultimately produce since the stochastic component
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of the overall model is increased by removing variability from the dependent variable
(see Gordon 2012). Since it is impossible to determine if the amount of error being
reduced by removing MNAR-afflicted cases is greater than the error introduced by
delimiting the sample, and because delimiting the sample reduces statistical power, this
approach was rejected. A second means to reduce error is to exclude cases taken from
the MNAR subsamples if the total subsample does not meet a sample size
threshold. This approach is predicated on the notion that larger subsamples should
produce point estimates with less error. Although this is probably true for MCARaffected cases, it is not necessarily true for MNAR-afflicted cases. Additionally,
delimiting the sample increases the model's stochastic component, as mentioned
previously. Given these problems with the second approach, I opted for a third approach
which is to adjust the inflation of the error in the models arising from the inclusion of
MNAR-afflicted cases by calculating sandwich estimators of the standard errors. Thus,
the standard errors presented here represent Huber-White estimators, and the p-values are
more conservative (reducing the chance of Type I errors). This approach is assumed to
be superior to the other two approaches, since it also accounts for the violation of
identical variance problem in the overall model and conserves statistical power.
Eight models were developed to test the six hypotheses. The first model tests the
hypothesis one, the second hypothesis two, the third hypothesis three, the fourth
hypothesis four, and the fifth hypothesis five. To test the sixth hypotheses, two models
were developed; one model uses the term biotechnology and the other the genetic
variable. Model eight is the full model. Table 5.2 presents the results for the eight
models (See note 1).
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Table 5.2 Effects of Dimensions on Concern Reported (robust standard errors in parentheses)
Model 1
Model 2
Model 3 Model 4
Model 5
Model 6
Year Survey Conducted
-.87
(.57)
Biotech Food
12.31*
(4.19)
Biotech Crops
14.95*
(6.44)
Biotech Crops and Animals
14.33
(9.23)
Animal Aspect
12.67*
(5.23)
Medical Aspect
.86
(4.02)
Human Health
2.35
(2.35)
Regulations
20.28***
(3.18)
Economics
-4.49
(3.00)
Other
4.93*
(1.75)
Local Level
-5.24*
(2.35)
National/Global Level
11.99*
(4.51)
Level Not Specified
--Future

.65
(3.83)
---

Present/Past
Belief

---

Attitude

-10.22***
(2.40)
-7.34
(4.01)

Behavior
Biotechnology

-11.19*
(4.31)

Genetic
Constant
R Squared
F

1786.10
.03
2.38

17.69
.19
9.59***

34.23
.05
6.80*
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34.20
.00
.03

39.04
.04
9.91**

39.76
.07
6.74*

Model 7
Year Survey Conducted
Biotech Food
Biotech Crops
Biotech Crops and Animals
Animal Aspect
Medical Aspect
Human Health
Regulations
Economics
Other
Local Level
National/Global Level
Level Not Specified
Future
Present/Past
Belief
Attitude
Behavior
Biotechnology
Genetic

12.16*
(4.01)
Constant
30.33
R Squared
.07
F
9.21*
* p<. 05; **p<. 01; ***p< .001 (n=269)

Model 8
-1.56**
(.45)
16.64
(7.92)
17.45*
(7.79)
8.69
(9.18)
25.43***
(5.16)
-3.77
(4.40)
.28
(3.26)
11.81
(8.38)
.98
(3.93)
5.35
(2.89)
-4.51
(5.80)
3.05
(6.28)
---.10
(6.61)
-----5.38
(3.57)
-1.78
(8.24)
-9.14
(8.81)
2.53
(6.54)
3155.08
.31
6.76***
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RESULTS
The bivariate relationship between percent concern expressed and time is
examined in model one. Time is the year that the survey was administered, and I
expected that US residents’ concerns about biotechnology might increase or decrease
with time. Either US residents might become more concerned with biotechnology as
problems have become publicized and biotechnology has become more widespread, or
US residents might become less concerned over time as biotechnology becomes more
prevalent. The results of the t- and F- tests provide no support for Hypothesis 1. Biotech
concern has not changed significantly over time, at least not in a discernible linear
fashion.
In the second model, the relationship between concern expressed and the
substantive dimension measured by the survey question were assessed. In this model,
significantly more concern was expressed over questions about biotech food than
questions not about biotech food (b=12.3, p<.05). The same is true for the relationships
between concern and crops (b=15.0, p<.05; verses questions not about crops), concern
and animals (b=12.7, p<.05; verses questions not about animals), and concern and
regulation (b=20.3, p<.001; versus questions not about regulation). The coefficient of
determination (R-squared) is .19, meaning 19 percent of the variance in concern
expressed is explained by the substantive dimensions of the questions being posed. In
other words, people express more or less concern about biotechnology depending on
what element of biotechnology is being tapped by the question.
The third model assesses the relationship between concern expressed and the
spatial dimension addressed in the survey questions. Significantly more concern was
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expressed over questions not centered at the local level compared to when the level was
not specified (b= 12.0, p<.05). Significantly less concern was expressed over questions
centered at the local level compared to when the level was not specified (b= -5.2, p<.05).
The coefficient of determination (R-squared) for this model is .05, which means that the
spatial dimension explains five percent of the variance in concern expressed.
Model 4 examines the relationship between concern and the temporal dimension
tapped by the survey questions, and Model 5 assesses the relationship between concern
and the theoretical dimension (i.e. beliefs, attitudes or behaviors) captured by the research
question. Significantly less concern is expressed over attitudinal questions (b= -10.2,
p<.001) compared to questions asking for beliefs. No significant relationships were
found in the temporal model.
The sixth model examines the relationship between concern expressed over
questions using the term biotechnology and those using some term other than
biotechnology to depict the technology. Interestingly, significantly less concern was
expressed over questions using the term biotechnology than questions using a different
terminology (b=-11.2, p<.05). That is, 11.95 percent less concern was expressed, on
average, when questions used the word biotechnology instead of something else. The
coefficient of determination (R-squared) for the model is .07. This finding is consistent
with that of the 2010 Eurobarometer (European Commission 2010).
The relationship between concern expressed over questions using the terms
genetic alteration, modification, or engineering and those using some other term was
examined in Model 7. Significantly more concern was expressed (b=12.2; p<.05), on
average, when the question used one of these terms to depict the technology instead of
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another term. The use of this terminology explains about seven percent of variance in
concern expressed.
Model 8 reports the results of the full model, which includes all of the predictors
in this study. The results of the final model support the first hypothesis, indicating that
the percent of concern reported has significantly varied over time (b=-1.6, p<.01). That
is, for each subsequent year of polling, the concern expressed has decreased by a 1.56
percent. Recall from model one that the results of the simple regression t-test indicate
that time does not have a significant effect on concern expressed. According to
MacKinnon and colleagues (2000), when a bivariate model becomes more significant
when adding variables suppression is occurring. This indicates that omitted variables
(i.e., the other variables in the full model) in the bivariate model are suppressing the
effect of time on concern. Additionally, the magnitude of the coefficient for time
increased, which also indicates that suppression is occurring (See note 2: MacKinnon et
al. 2000).
The final model also indicates the concern expressed varies by the variables in the
substantive dimension, when other factors are accounted for, which supports the second
hypothesis. Use with animals was significant at the p<.001 level. Respondents
expressed 25.4 percent more concern over questions about biotechnology use with
animals than over questions not about animal use. Additionally, 17.5 percent more
concern was reported for questions about crop use than questions not about crop use
(p<.05). The remaining hypotheses were not supported when other dimensions were
controlled; none of the variables in the spatial, temporal, theoretical, or linguistic
dimensions varied significantly. Overall, as indicated by the coefficient of determination
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(R-squared), the final model explained 31 percent of the variation in US public concern
about biotechnology.
NOTES
1

Previous research has indicated that attitudes, beliefs, and behaviors may vary in their

predictive power (see Schahn and Holzer 1990; Schultz and Oskamp 1996; Wicker
1969). That is, attitudes, beliefs, and behaviors my not be equivalent indicators of
concern. However, for models 5 and 8, the behavior variable is weighted the same as
attitudes and beliefs.
2

A possible alternative to a suppression effect is an interaction between time and another

variable. To test this, I created and tested interaction terms of time and every other
variable in the model (one at a time), but I found no significant interactions. This further
confirms suppression due to omitted variable bias.
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CHAPTER SIX
CONCLUSION
In the debate over biotech development, US residents are framed as less
concerned than EU members (see Bhargava 2002; Herdt 2006; Hoban 2004; Peacock
2010; Pechlaner and Otero 2008; Stone 2010). The European Union has systematically
studied member concern since 1991 (European Commission 2010). There has been no
comprehensive study on US public concern for biotechnology. Instead, US studies have
tended to be ad hoc, a-theoretical, and non-accumulative (see Hoban 2004; Lusk et al.
2005). This has thwarted the development of a comprehensive literature and created a
need to synthesize the fragmented studies. The goal of this work is to provide framework
to organize extant work.
Because there is no standard conceptualization and measurement of and no clear
consensus on US public concern for biotechnology (see Lusk et al. 2005), the literature
had become difficult to summarize (Lusk et al. 2005). What are US residents concerned
about when it comes to biotechnology, and how concerned are they? These questions
guided the research in this project and informed the project’s two aims: to identify the
different dimension of biotech concern and examine if and how concern varies over time.
To accomplish these aims, I conducted a literature review on the biotech debate,
developed a framework to unite the fragmented studies, and applied the framework to 22
studies on US biotech concern.
The framework I developed for conceptualizing and measuring US public concern
for biotechnology is modeled off the framework developed by Dunlap and Jones (2002)
for conceptualizing and measuring environmental concern. The rationale for employing
their framework is based off similarities in conceptual and measurement issues for
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environmental and biotech concern: both have multiple sub-objects, lack a standardized
definition and measurement, and resulted in a disorganized literature.

Applying Dunlap

and Jones’ framework, there are two components to biotech concern: the biotech and
concern component. To conceptualize and measure the concern component, I largely
retained their use of attitude theory and the scale developed by Maloney and Ward
(1973). To get at the biotech component, however, I could not as easily retain their
conceptualization and measurement of the environment.
Although I adopted the temporal, spatial, and specificity dimensions, I had to
identify the content-specific dimensions of biotechnology. To accomplish this, I
conducted a content analysis of the questions asked in each study, identifying the object
of interest; I also relied on the major divisions suggested in the literature. In the biotech
debate, conflicting claims have largely been over food and medicinal uses, human,
environment, and societal health effects, and regulation. Based off this, I developed 10
content-specific dimensions: biotechnology’s use with plants and animals for food
production or medicinal purposes, application to cloning, affect on human,
environmental, or social (i.e. primarily economic) health, and as a solution to world
hunger and a petro-dependent agricultural system.
WHAT DOES CONCERN THE US PUBLIC?
Much of the literature indicates that the US public is concerned about regulation
(see Hoban 2004; Stilwell and Van Dyke 1999). The United States adheres to a productrisk approach that has been criticized for simple approval procedures (see McGiffen
2005; Vogel 2001), fostering corporate growth and market control (Moses 1999;
Sheingate 2006), and equating risk assessment with scientific assessment (Jasanoff 2005).
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The European Union adheres to the precautionary principle, which has been criticized as
a form of protectionism (Sheingate 2006). Regulatory disputes peaked in 2003 when the
United States, with Argentina and Canada, filed an official compliant with the WTO
against the European Union. With so much international attention on regulation, it may
not be surprising that the US pubic is concerned.
When it comes to regulation, the US public is especially concerned with labeling
(Hoban 2004). The majority of the public has repeatedly reported support for mandatory
labeling (ABC 2003; Peacock 2010; Pew Initiative on Food and Biotechnology 2004);
however the United States has yet to adopt such a policy. Labeling has been called the
most controversial regulatory issue in the United States (Hoban 2004), which may
explain why nearly half (49 percent) of regulatory questions in this study were on
labeling. Most relevant is Proposition 37, known as the California Right to Know
Genetically Engineered Food Act. Proposition 37 represents the biggest step taken in the
United State to mandate labeling (Huff 2012). Up for vote in November, if passed, all
foods containing biotech ingredient sold at the retail level in California will have to be
labeled. So far, Monsanto has donated $4.2 million, DuPont $1.2 million, and others
(e.g. such as PepsiCo, Nestle, Coca-Cola, Bayer Cropscience, ConAgra, and Kellogg’s
Company) additional millions to defeat Proposition 37 (Huff 2012).
To understand the concern expressed over regulation and labeling, the various
dimension of biotech concern, particularly human, environmental, and societal health
effects from adopting biotech practices, need to be examined. In the literature on biotech
concern, the naturalness of biotechnology is at the forefront (see Cummings 2008;
Persley and Peacock 1993; Stone 2010). Some view biotechnology as a scientific
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advancement over conventional breeding (Stone 2010), which constitutes progress and
little concern. Others, however, view biotechnology as a technological advancement that
warrants concern over its scientific basis (see Cummings 2008). Human health concerns
range from biotech products causing developmental abnormalities (see Goldstein and
Emami 2010; Hirschler and Kelland 2012) to biotech feedstock accidently mixing with
the human food supply (see Cummings 2008; Schneider and Schneider 2006). Key
environmental concerns include biotechnology’s contribution to widespread pesticide use
(see Peacock 2010; Stilwell and Van Dyke 1999), the loss of biodiversity (see Shelton,
Zhao and Roush 2002; Qaim 2009), increased rates of soil erosion (see Peacock 2010;
Shiva 1991), and the evolution of super weeds (see Asian Development Bank 2001;
Avise 2004). Social health effects are characterized by the question, “who benefits from
the spread of biotechnology?” Many claim that the widespread adoption of
biotechnology has resulted in a shift in power and wealth from the public to the private
sector (see Asian Development Bank 2001; Cummings 2008; Food and Water Watch
2011). At the core of these concerns, however, is the naturalness of biotechnology (i.e.
the conflation of biotech products with scientific advancements).
HOW CONCERNED IS THE PUBLIC?
The results from chapter five indicated that 34.4 percent of respondents in the
questionnaires examined reported concern regardless of the dimension being tapped. It
is important to note that the 34.4 percent of respondents that reported concern is an
average, taken from a range. The standard deviation, however, was quite large (22.46),
which means reported concern varied widely by the dimension(s) asked about in the
question. With such a large standard deviation, it is useful to examine the actual levels of
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concern elicited by the questions. Table 6 displays the range of concern reported for the
content-specific dimension.
As can be seen from table 6, there is considerable variation in concern reported in
each dimension. Although the results from the full regression model indicate that use
with animals and crops are the only dimensions where reported concern is significantly
different than concern reported for other dimensions, the literature review suggests that
the US public’s concern is much more varied. Since biotech products first became
commercially available in 1995, a wide array of issues has been discussed in the biotech
debate.
The results from the full regression model indicate that US public concern over
biotechnology has decreased by about 1.6 percent per year. The rise in US residents selfreporting less awareness may contribute to declining concern. The likelihood to report
strong concern may be mitigated by the recognition of one’s own lack of knowledge.
That is, studying concern about an issue most admittedly know little about, compared to
an issue most are well informed about, may be more likely to find neutral results. It
would be interesting to further examine the mechanisms contributing the decline in US
public concern.
LIMITATIONS AND FUTURE RESEARCH
Although this study examines nearly 20 years of survey data, the bulk of data,
including longitudinal data comes from the IFIC and the Pew Initiative on Food and
Biotechnology (See note 1). Additionally, some years have few questions that were
included in the analysis. For example, in 1993 only four questions were included. To
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account for these limitations, the database should be expanded to include more data from
a variety of sources and across time.
Table 6. Range of Concern Reported for Content-Specific Dimension
Dimension
Question
Percent Concern
Biotech Food
“Do you think the federal
93
government should or should
not require labels on the food
saying whether it has been
genetically modified or
bioengineered?”

Biotech Crops

Animals and Crops

Source for Question
(International Food
Information Council
[IFIC] 2007)

“Thinking about your diet over
the last few months, are there
any foods or ingredients that
you have avoided?”

0

(IFIC 2007)

“Do you think the government
should require the labeling of
all packaged and other food
products saying that they
include corn, soy or other
products which have come
from genetically modified
crops, or is that not important?

86

(Taylor 2000)

“What is your overall
impression of using
biotechnology to produce
medicines from food crops such
as corn and rice? “

6

(IFIC 2007)

“How likely do you think it is
that animals, plants or bacteria
which are produced by genetic
engineering will pose a serious
threat to human life or the
environment?”

60

(Taylor 1993)

“Now I’m going to list some
reasons to genetically modify
plants or animals. For each
item I read, please tell me if
you think it is a good reason to
genetically modify plants and
animals. If you aren’t sure how
you feel about a specific item,
just say so and we’ll move on.
To produce more affordable
pharmaceutical drugs by using
plants to produce
pharmaceutical compounds.”

14

(Pew Initiative on
Food and
Biotechnology
2004)
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Table 6. Range of Concern Reported for Content-Specific Dimension Continued
Dimension
Question
Percent Concern Source for Question
Animal Aspect
“If the FDA approves this
91
(Lake Research
genetically engineered salmon
Partners 2010)
it will be the first time any
genetically engineered fish or
animal has been approved and
allowed into the American food
supply. Research is already
underway to put engineered
pigs, chickens, and cattle into
the food supply once salmon is
approved, even though the FDA
has conducted no safety tests of
its own. What do you think?
Should the FDA ALLOW these
genetically engineered meats
and fish into the market before
the FDA performs its own
studies, or should it NOT allow
it until the FDA performs its
own studies?

Medical Aspect

“Now Please read the following
statements regarding the
potential benefits of animal
biotechnology. As you read
each one, please indicate
whether the information has a
positive effect on your
impression, a negative effect, or
no effect at all. Animal
biotechnology can improve the
quality and safety of food.”

12

(IFIC 2007)

“Do you think the federal
government should or should
not require labels on food
saying whether it’s from farm
animals that have been fed
antibiotics or hormones?

85

(American
Broadcasting
Corporation [ABC]
2003)

“Do you support or oppose the
use of biotechnology to develop
new medicine to treat human
diseases?”

5

(Miller 1998)
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Table 6. Range of Concern Reported for Content-Specific Dimension Continued
Dimension
Question
Percent Concern
Human Health
“I’m going to list some things
85
people tell us they are
concerned about when it comes
to food safety. After each,
please tell me whether it is one
of the things that worries you
most about food safety, whether
it worries you a great deal,
some, not too much, or not at
all. If you are not sure, please
say so and we’ll move on.
Food freshness.”

Regulations

Economic

Source for Question
(Pew Initiative on
Food and
Biotechnology
2001)

“What if anything concerns you
when it comes to food safety?”

2

(IFIC 2010)

“Do you believe that foods
should be labeled to indicate
that they have been genetically
engineered or contain
ingredients that have been
genetically engineered?”

93

(National Public
Radio and Thomas
Reuters 2010)

“Can you think of any
information that is not currently
included on food labels that you
would like to see on food
labels?”

1

(IFIC 2007)

“I’m going to list some things
people tell us they are
concerned about when it comes
to food safety. After each,
please tell me whether it is one
of the things that worries you a
great deal, some, not too much,
or not at all. If you are not
sure, please say so and we’ll
move on. Chemicals and
fertilizers being used in the
production of food.”

78

(Pew Initiative on
Food and
Biotechnology
2001)

“What is your overall
impression of using
nanotechnology in food
production or packaging for
such purposes as extending
freshness, decreasing the risk of
foodborne illness, and
improving nutrition?”

8

(IFIC 2010)
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Additionally, it may be more accurate to use hierarchical analysis to replicate this study.
The data could be viewed as clustered in questionnaires by year. Historic events have
greatly impacted public concern, and by using OLS regression that those event-specific
impacts may be lost.
Lastly, expanding this study to include an analysis comparing US and EU public
concern is a logical direction for this work to proceed. The Eurobarometer measures
concern using a number of similar variables (e.g. attitudes, beliefs, and knowledge) as the
framework suggested here. It also provides the actual questionnaire and counts or
percentages for the responses provided. The database could be expanded to include EU
data rendering a comparable analysis quite feasible.

NOTES
1

The IFIC is one of the oldest and few organizations to study the US biotech concern in a

consistent manner over time; it has been criticized, however, for the bulk of its support
coming from corporate funders (e.g. Aventis, Cargill, Inc., Coca-Cola Company, Dow
AgroSciences, LLC. and DuPont; Branden 2002).
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Appendix A. Timeline for International Development of Biotechnology
Year
Event
Description
1972
First experiment using rDNA
Conducted by Paul Berg at Stanford University
1973

Invention of first procedure to transfer
genes from one organism to another

Invented by Stanley Cohen and Herbert Boyer, called
the process “rDNA”

First conference about using rDNA

Organized by the National Science Foundation’s
Human Cell Biology Steering Committee and the
National Cancer Institute to discuss carcinogenic risks

1974

Recombinant DNA Advisory
Committee formed

Division of the National Institutes of Health formed to
ensure the safety of experiments using rDNA

1975

Asilomar Conference held in
California

Organized by Paul Berg to establish guidelines to
ensure the safety of experiments with rDNA

1976

First biotechnology firm established

US-based Genentech

First guidelines for using rDNA
established

RAC issued a set of guidelines governing work using
rDNA

Diamond v. Chakrabarty

First US Supreme Court ruling that permitted the
patenting of life, a biotech bacteria that digests
petroleum

First rDNA procedure patented

Awarded to Cohen and Boyer

First biotech medicine became
commercially available

Synthetic human insulin, engineered by Genentech,
marketed by Eli Lilly

First successful transgenic animal
created

Richard Palmiter and Ralph Brinster implanted a rat
growth hormone into a mouse

1983

RAC approved first biotech organism
to be released in environment

Application from the University of California,
Berkeley for the field-testing of Ice Minus approved

1984

The White House Cabinet Council on
Natural Resources is established

Established by the Reagan Administration, determined
the current regulatory framework is suitable to regulate
biotechnology, currently known as the Domestic Policy
Council Working Group on Biotechnology

1985

First biotech seed developed

A Bt tobacco plant, developed by the Belgian Plant
Genetic Systems

1986

US Coordinated Framework for the
Regulation of Biotechnology
established

First federal policy statement specific to biotechnology,
established all biotech varieties as GRAS and thus
regulated by existing framework

The Toxic Substances Control Act
amended

Amended to include regulation over biotech organisms

First biotech organism released into
the environment

Ice Minus bacteria, developed at the University of
California at Berkley, released

The Plant Pest Act is passed

Granted the USDA the right to regulate biotech

1980

1982

1987
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products that are considered pests
1988

First biotech animal patented

Known as the Oncomouse, patented by Harvard, used
in cancer research

First biotech crop commercially
grown

Tobacco plant modified to resist the tobacco mosaic
virus, adopted in China

1989

First biotech genes inserted into
human

Steven A. Rosenberg inserted genes to treat cancer

1990

Human Genome Project launched

Spearheaded by the National Center for Human
Genome Research, headed by James D. Watson

EU’s Directive 90/220/EEC took force

Established a process for the assessment and approval
of biotech products

1992

FDA’s Statement of Policy: Foods
Derived form New Plant Varieties
issued

FDA stated their interpretation of the FFDCA in
relation to biotechnology in foods and feed

1994

Palmiter and Brinster awarded the
Charles Leopold Mayer prize

Due to their 1982 creation

First biotech food marketed to US
consumers

Calgene’s Flavor Savr tomato; unsuccessful yields led
to discontinuation

Germany passed Genetic Engineering
Act

Protects framers whose crops have become
contaminated with biotech seed

1995

World Trade Organization’s TRIPS
goes into effect

Article 27.1 states that patents should be available for
any invention or process in all fields of technology;
Article 30 extends intellectually property rights to
plants

1996

Roundup-Ready Soybeans launched

Monsanto’s seeds that are bioengineered to withstand
the company’s Roundup herbicide

Hamburg dockworkers protest

Refused to unload 200,000 tons of Monsanto’s biotech
soybeans that were approved for import by the
European Commission

Introduction of the first commercial
biotech product in Europe

A tomato paste derived from Calgene’s Flavr Savr
tomato

First organism, a sheep named Dolly,
cloned

Ian Wilmut of the Roslin Institute in Scotland
announces in Nature that he has cloned Dolly

EU’s Regulation No. 258/1997
entered into force

Requires labeling of novel food products containing
biotech ingredients; simplified the approval procedure
for biotech food products

South Africa passed the Genetically
Modified Organism Act

Regulates the planting of biotech crops

Mexico banned the growth and sale of

Banned due to concern about gene flow

1997

1998
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biotech maize

1999

2000

2001

2002

2003

Alliance for Bio-Integrity, et al. vs.
Shalala

A coalition of interest and religious groups filed a
lawsuit in the District of Columbia against the FDA to
obtain mandatory safety testing and labeling; court
ruled in the FDA’s favor

Creation of Golden Rice

Invented by Ingo Potrykus and Peter Beyer to help
children in developing countries alleviate malnutrition

First biotech animal marketed as a pet

A fluorescent zebrafish that contains a jellyfish gene
for phosphorescence, known as GloFish, originally
developed to glow in the presence of pollution

Commencement of EU’s six-year
moratorium on biotechnology

Resulted in EU not permitting the sale or use of biotech
products or processes

First large US company refused to sell
biotech food products

Pledge made by Hain Food Group

Monsanto merged with Pharmacia

Created a agrochemical and biotech subsidiary

StarLink Incident

Bt corn manufactured by Aventis Crop Science, only
approved for livestock feed, found in US taco shells

US Plant Protection Act

Consolidated ten USDA policies into one

President’s Council on Bioethics
established

Addresses ethical issues raised by biomedical science
and technology; established under George W. Bush

Germany establishes Bio-Seigel

A seal of approval to certify organic products

The Human Proteome Organization is
founded

Founded to build upon the findings of the Human
Genome Project with a focus on customized medical
treatment

Chapela and Quist discover biotech
corn growing in Oaxaca, Mexico

Published study in Nature, states that biotech corn has
contaminated native varieties despite national ban

EU’s Directive 2001/18/EC took force

Instituted the safeguard clause, allowing member-states
to impose national bans

FDA’s Premarket Notification
Proposal

Requires developers to submit scientific and regulatory
assessment of biotech product 120 days prior to
marketing

Japan’s Biotechnology Strategy
Council adopted Biotechnology
Strategy Guidelines

Developed and adopted a guide to economic
development

Africa rejects World Food Program
(WFP) aid

Rejected because it was contaminated with biotech
corn; WTP responded that it was impossible to discern
biotech from non-biotech corn and that it did not matter
anyway because biotech corn is safe for consumption

United States, along with Argentina

Stated that the EU anti-biotech food policies violate
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and Canada, filed complaint with
WTO

international trade agreements

Cartagena Protocol on Biosafety
entered into force

International agreement aimed at protecting native
varieties from being contaminated with biotech
varieties; promotes precautionary principle; allows
individual countries to ban use or sale of biotech
processes or products

EU’s Regulation No. 1829/2003
entered into force

Established a regulatory system for developers; ran by
European Food Safety Authority

EU’s Regulation No. 1830/2003
entered into force

Requires labeling of all food and feed containing over
.9 percent of biotech ingredients; mandates businesses
to track all biotech products through the commercial
food chain

Monsanto successfully sues Oakhurst
Dairy in Maine

Dispute over Oakhurst Dairy labeling its milk as
having come form cows not treated with rBGH

Monsanto Canada, Inc. v. Schmeiser

Supreme Court of Canada ruled that farmer Percy
Schmeiser has violated Monsanto’s patent on canola
seed by inadvertently planting and storing Roundup
Ready canola on his fields

Monsanto had filed over 90 lawsuits

All against farmers for patent violations

Half of world seed sales owned by six
agricultural corporations

This included: Bayer, Advanta, Limagrain, Syngenta,
Monsanto, and DuPont

Inspector General cites USDA’s
Animals and Plants Health Inspection
Services

Cited for failure to adequately regulate biotechnology

2006

Rice shipments to Europe
contaminated with biotech rice

Biotech rice was not approved to be commercially sold
in United States

2007

Complete human genome published

Published by Celera Genomics

2008

Svalbard Global Seed Vault in the
Artic Circle opened

Housed in Norway, is the largest seed repository in the
world

India’s Prime Minister Manmohan
Singh called for a second Green
Revolution

Called on biotechnology to increase crop yields and
eliminate hunger

One billion hectares of biotech crops
grown worldwide

Biotech crops planted by 15.4 million farmers in 29
countries

2004

2005

2010
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Appendix B. Description of and Notes on Data Sources
Source
Description of Source
Notes
American
Telephone poll conducted in
Supplemented findings with data from a 1997
Broadcasting
2003 on confidence in US
Wirthlin Group study that was omitted from
Corporation
regulation of biotech foodstuff analysis, n was undefined in their own 1997 study
that was also reported
Gallup Poll

Telephone survey conducted
in 2001 on US attitudes and
reactions towards the use of
biotechnology in food
production

Also included data from same questions asked in a
separate 1999, 2000, and 2001 survey for all of
which n was undefined

Gallup Poll

Telephone survey conducted
in 2005 centered on biotech
support in Britain, Canada,
and the United States

Only US data were included

Harris Poll No. 33

Telephone poll conducted in
2000 about the labeling, risks,
and knowledge of
biotechnology

Reported and recorded a combined percentage for
“don’t know” and “refused”

Harris Poll No. 35

Telephone poll conducted in
1993 centered on the attitudes
and risks associated with
biotechnology and the movie
Jurassic Park

Omitted question two because it only pertained to
the movie

International Food
Information Council

Web-based survey conducted
in 2001, 2006-08, and 2010
that focused on many of the
dimensions of biotech concern

2006: Switched from telephone-based survey to
web-based; reported and recorded a combined
percentage for “don’t know” and “refused”
2008: Reported data for 8a, but not 8b
2010: Nanotechnology first included under “other”

Harris Interactive
and the Chicago
Council on Foreign
Relations

Combination of telephone and
in-person survey focusing on
foreign-policy issues in 2002

Only included two questions from data collected
on the general public and one from that collected
from official leaders

International Social
Survey Program

International survey on major
environmental problems
conducted in 2000

Only included one question

Inter-University
Consortium for
Political and Social
Research (ICPSR)
No. 3030

Telephone-based survey
conducted in 1996-1997 aimed
at capturing consumer trends
in biotechnology

Last year of the two year study was recorded as
year conducted; first 48 questions were omitted
because they were unrelated to biotechnology

ICPSR No. 2874

Web-based poll conducted in
1999 that focused on
anticipation of life in 21st
century

Only included on question

ICPSR No. 6952

Written survey administered in

Only included one question from US data
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the United States and Japan in
1993 that was centered on
attitudes and risk perception
Lake Research
Partners

Report issued in 2010 on
attitudes towards genetically
modified foods

---

National Public
Radio (NPR)

Telephone survey conducted
in 1999 on knowledge about,
attitudes towards, and access
to technology

Only included two questions; only included
responses from adults 18 or older

Pew Initiative on
Food and
Biotechnology

Telephone surveys conducted
in 2001, 2003, and 2004 about
public opinion on
biotechnology

---

Thomas Reuters and
NPR

Telephone survey conducted
in 2010 on consumer attitudes
towards genetically modified
food

For question four, had to interpret responses based
on measurements in previous scales
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Appendix C. Description of Codes
Code
Description
Biotech Food
Addresses need to specify within the data between biotech food, crops, and animals;
concerned with biotech food that was not specified as pertaining to crops or animals
Biotech Crops

Refers to plants grown to produce food for human consumption or feedstock; is one of
three major divisions in biotechnology

Animal Use

Concerned about issues specific to animal biotechnology; is one of three major divisions
in biotechnology

Biotech Crops
and Animals

Indicates if both biotech crops and animals are both expressed in the question

Medical Use

Concerned with issues specific to medical biotechnology; is one of three major divisions
in biotechnology

Human Health

Concerned with human health issues other than those specific to medical use, many of
which are concerned with only the general application of biotechnology

Environmental
Health

Concerned with disrupting the atmosphere, biosphere, hydrosphere, or lithosphere and
associated consequences

Regulations

Centered on biotech regulation at all spatial levels; includes labeling

Labeling

Differentiated from regulations because of prominence in biotech literature and studies

Economics

Concerned with private and public market sector; includes consumer preferences

Cloning

Concerned with issues specific to animal or human cloning; one of top reported concerns
in biotechnology

Pesticide Use

Concerned with pesticide use; petrochemical use has been increasing since 1970s, and
biotech products are often touted as reducing the need for pesticides

Human
Hunger

Concerned with alleviating human hunger; has been used as a justification for the
international proliferation of biotech practices and products

Other

Concerned with issues other than those mentioned above; the “catch-all” category
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Appendix D. Questions Included by Source and Percent Concern Expressed
Source
Question
(American
Broadcasting Station
2003)

How confident are you that the food we eat in the United States is
safe...very confident, somewhat confident, not very confident or not at
all confident?

Percent
Concern*
12

How confident are you that the food we eat in the United States is
safe...very confident, somewhat confident, not very confident or not at
all confident?

16

Scientists can change the genes in some food crops and farm animals
to make them grow faster or bigger and be more resistant to bugs,
weeds and disease. Do you think this genetically modified food, also
known as bioengineered food, is or is not safe to eat?

46

Do you think the federal government should or should not require
labels on food saying whether it has been genetically modified or
bioengineered?

92

If you saw a label on food at your market saying it had been
genetically modified or bioengineered, would you be more likely to
buy it, less likely to buy it, or would it make no difference in your
buying decision?

55

If you saw a label on food at your market saying it had not been
genetically modified or bioengineered, would you be more likely to
buy it, less likely to buy it, or would it make no difference in your
buying decision?

51

Currently do you try to avoid buying genetically modified or
bioengineered foods, or is that not important to you?

34

Some livestock and poultry are fed antibiotics and hormones to make
them disease resistant and faster growing. Do you think food from
farm animals that are fed antibiotics and hormones is or is not safe to
eat?

42

Do you think the federal government should or should not require
labels on food saying whether it’s from farm animals that have been
fed antibiotics or hormones?

85

If you saw a label on food at your market saying it’s from farm animals
that have been fed antibiotics or hormones, would you be more likely
to buy it, less likely to buy it, or would it make no difference in your
buying decision?

47

If you saw a label on food at your market saying it’s from farm animals
that have not been fed antibiotics or hormones, would you be more
likely to buy it, less likely to buy it, or would it make no difference in
your buying decision?

46

Do you try to avoid buying foods from farm animals that have been fed
antibiotics or hormones?

32

Scientists can change the genes in some food crops and farm animals

52
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to make them grow faster or bigger and be more resistant to bugs,
weeds and disease. Do you think this genetically modified food, also
known as bioengineered food, is or is not safe to eat?
Do you think the federal government should or should not require
labels on food saying whether it has been genetically modified or
bioengineered?

93

If you saw a label on food at your market saying it had been
genetically modified or bioengineered, would you be more likely to
buy it, less likely to buy it, or would it make no difference in your
buying decision?

57

(Central
Broadcasting
Station1999)

Genetic engineering can also be used to alter the make-up of plants,
fruits and vegetables. Do you think it's right or wrong to use scientific
techniques to do things like enhance the flavor and nutrients, or
prolong the freshness of food?

29

(Gallup Poll 2001)

Do you feel confident or not confident that the food available at most
grocery stores is safe to eat?

10

Do you feel confident or not confident that the food available at most
grocery stores is safe to eat?

18

Do you feel confident or not confident that the food available at most
grocery stores is safe to eat?

18

Do you feel confident or not confident that the food available at most
grocery stores is safe to eat?

19

Do you feel confident or not confident that the food served at most
restaurants is safe to eat?

21

Do you feel confident or not confident that the food served at most
restaurants is safe to eat?

29

Do you feel confident or not confident that the food served at most
restaurants is safe to eat?

30

How much confidence do you have in the federal government to
ensure the safety of the food supply in the U.S., would you say you
have -- a great deal, a fair amount, not much, or none at all?

17

How much confidence do you have in the federal government to
ensure the safety of the food supply in the U.S., would you say you
have -- a great deal, a fair amount, not much, or none at all?

20

How much confidence do you have in the federal government to
ensure the safety of the food supply in the U.S., would you say you
have -- a great deal, a fair amount, not much, or none at all?

24

As you may know, some food products and medicines are being
developed using new scientific techniques. The general area is called
"biotechnology" and includes tools such as genetic engineering and
genetic modification of food. How much have you heard or read about
this issue -- a great deal, some, not much or nothing at all?
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As you may know, some food products and medicines are being
developed using new scientific techniques. The general area is called
"biotechnology" and includes tools such as genetic engineering and
genetic modification of food. How much have you heard or read about
this issue -- a great deal, some, not much or nothing at all?
As you may know, some food products and medicines are being
developed using new scientific techniques. The general area is called
"biotechnology" and includes tools such as genetic engineering and
genetic modification of food. How much have you heard or read about
this issue -- a great deal, some, not much or nothing at all?
As you may know, some food products and medicines are being
developed using new scientific techniques. The general area is called
"biotechnology" and includes tools such as genetic engineering and
genetic modification of food. How closely have you been following the
news about this issue --very closely, somewhat closely, not too closely,
or not at all?

(Gallup Poll 2005)

Overall, would you say you strongly support, moderately support,
moderately oppose or strongly oppose the use of biotechnology in
agriculture and food production?

38

Overall, would you say you strongly support, moderately support,
moderately oppose or strongly oppose the use of biotechnology in
agriculture and food production?

41

Overall, would you say you strongly support, moderately support,
moderately oppose or strongly oppose the use of biotechnology in
agriculture and food production?

41

From what you know or have heard, do you believe that foods that
have been produced using biotechnology pose a serious health hazard
to consumers, or not?

30

From what you know or have heard, do you believe that foods that
have been produced using biotechnology pose a serious health hazard
to consumers, or not?

30

From what you know or have heard, do you believe that foods that
have been produced using biotechnology pose a serious health hazard
to consumers, or not?

27

As you may know, some food products and medicines are being
developed using new scientific techniques. The general area is called
"biotechnology" and includes tools such as genetic engineering and
genetic modification of food. How closely have you been following the
news about this issue--very closely, somewhat closely, not too closely,
or not at all?
Overall, would you say you strongly support, moderately support,
moderately oppose or strongly oppose the use of biotechnology in
agriculture food production?

45

From what you know or have heard, do you believe that foods that

33
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have been produced using biotechnology pose a serious health hazard
to consumers, or not?
Harris Interactive
and the Chicago
Council on Foreign
Relations 2002)

Overall would you say you strongly support, moderately support,
moderately oppose, or strongly oppose the use of biotechnology in
agricultural production?

45

Do you think that the European Union (EU) and Japan should be able
to require labeling of genetically modified food, even if this might
keep consumers form purchasing food imported form the U.S., or don’t
you think the European Union and Japan should be able to do this?
Do you think that the European Union (EU) and Japan should be able
to require labeling of genetically modified food, even if this might
keep consumers form purchasing food imported form the U.S., or don’t
you think the European Union and Japan should be able to do this?
(International
Food
Information
Council [IFIC]
2010)

Thinking about your diet over the past few months, are there any foods
or ingredients that you have avoided or eaten less of? [Biotech food]

0

[If yes] What food or ingredients have you avoided?
Can you think of any information that is not currently included on food
labels that you would like to see on food labels?

3

If yes, what types of information would that be?
How confident are you about the safety of the US food supply? Would
you say...?

12

What if anything concerns you when it comes to food safety? [Biotech
food]
As you may know, some food products and medicines are being
developed with the help of scientific techniques. The general area is
called "biotechnology" and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology? Would you say you have
read or heard...?
What is your overall impression of using biotechnology with plants
that produce food products? Would you say you are...?

19

As far as you know, are there any foods produced through
biotechnology in the supermarket now?
[If yes] Which foods would those be?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
[If yes] What benefits do you expect?
All other things being equal, how likely would you be to buy a variety
of produce, like tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher?
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All other things being equal, how likely would you be to buy a variety
of produce, like tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and required fewer
pesticide applications?

24

All other things being equal, how likely would you be to buy a food
product made with oils that had been modified by biotechnology to
avoid trans fats?

26

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to provide
more healthful fats, like Omega-3, in the food?

23

What is your overall impression of using biotechnology with wheat
and grains to produce food products such as bread, crackers, cookies,
cereals and pasta?

27

All other things being equal, how likely would you be to buy bread,
crackers, cookies, cereals or pasta made with flour from wheat that had
been modified by biotechnology to use less land, water, and/or
pesticides?

26

What is your overall impression of farmers using biotechnology to
grow more crops that would help meet food demand? Would you say
you are...?

16

The U.S. Food and Drug Administration (FDA) requires special
labeling when a food is produced under certain conditions: when
biotechnology's use substantially changes the foods nutritional content,
like vitamins or fat, or its composition; or when a potential safety issue
is identified. Otherwise, special labeling is not required. Would you
say that you strongly support, somewhat support, neither support nor
oppose, somewhat oppose or strongly oppose this FDA policy?
How much have you read or heard about applying the science of
biotechnology to animals? Would you say you have heard...?
What is your overall impression of using biotechnology with animals
that produce food products such as meat, milk, and eggs? Would you
say you are...?

27

[If not favorable] Why are you not favorable toward using
biotechnology with animals that produce food products? Check all that
apply.
Genomics is a form of animal biotechnology that uses knowledge
about the genetic makeup of farm animals to aid in producing better
offspring for improved meat, milk, and egg quality. What is your
overall impression of animal genomics?

22

Genetic engineering is a form of animal biotechnology that allows for
the transfer of beneficial traits from one animal to another in a precise
way that allows for improved nutritional content or less environmental
impact. What is your overall impression of genetic engineering in
animals?

29
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Now, please read the following statements regarding the potential
benefits of animal biotechnology and indicate whether the information
has a positive effect on your impression, a negative effect, or no effect
at all: animal biotechnology can increase farm efficiency; that is, it can
increase the amount of food produced while decreasing the amount of
resources needed, such as animal feed.

21

Please read the following statements regarding the potential benefits of
animal biotechnology and indicate whether the information has a
positive effect on your impression, a negative effect, or no effect at all:
animal biotechnology can improve the quality and safety of our food
(for example, through improved animal health or improved nutritional
quality of the food produced).

14

Please read the following statements regarding the potential benefits of
animal biotechnology and indicate whether the information has a
positive effect on your impression, a negative effect, or no effect at all:
animal biotechnology can reduce the impact of livestock, such as
animal waste, on the environment.

18

Since the U.S. Food and Drug Administration (FDA) has determined
that meat, milk, and eggs from animals enhanced through genetic
engineering are safe, how likely are you to buy them?

31

How much have you read or heard about applying the science of
nanotechnology in food applications? Would you say you have read or
heard...?
What is your overall impression of using nanotechnology in food
production or packaging for such purposes as extending freshness,
decreasing the risk of foodborne illness, and improving nutrition?
Would you say you are...?
How much have you read or heard about the concept of sustainability
in food production?
Please rank the following aspects of sustainability in order of
importance to you. Ensuring a sufficient food supply for the growing
global population.
Please rank the following aspects of sustainability in order of
importance to you. Land and water use and efficiency.
Please rank the following aspects of sustainability in order of
importance to you. Maximum output with minimal use of natural
resources.
Please rank the following aspects of sustainability in order of
importance to you. Less waste.
Please rank the following aspects of sustainability in order of
importance to you. Recyclable packaging.
Please rank the following aspects of sustainability in order of
importance to you. Lower carbon footprint.
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Please rank the following aspects of sustainability in order of
importance to you. Fewer food miles.
Please rank the following five factors related to growing sustainable
crops in order of importance to you. Growing more food on less land
so valuable land like rain forests is NOT destroyed/used as growing
space for increased food production.
Please rank the following five factors related to growing sustainable
crops in order of importance to you. Reducing the amount of
pesticides needed to produce food.
Please rank the following five factors related to growing sustainable
crops in order of importance to you. Growing more food to help feed
the growing global population.
Please rank the following five factors related to growing sustainable
crops in order of importance to you. Plants that use water more
efficiently, thereby conserving fresh water to help cope with predicted
droughts and water shortages.
Please rank the following five factors related to growing sustainable
crops in order of importance to you. Using conservation tillage
farming methods, which reduce soil loss and green house gas
emissions.

(IFIC 2008)

How likely would you be to purchase bread, crackers, cookies, cereal,
or pasta products containing wheat that was grown using plant
biotechnology, if they were produced using sustainable practices to
feed more people using less resources (such as land and pesticides)?

19

Thinking about your diet over the last few months, are there any foods
or ingredients that you have avoided or eaten less of? [Biotech food]

0

[If yes] What foods or ingredients have you avoided?
Can you think of any information that is not currently included on food
labels that you would like to see on food labels? [Biotech food]

1

[If yes] What?
How confident are you about the safety of the US food supply? Would
you say?

13

What, if anything, are you concerned about when it comes to food
safety? [Biotech food]
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called "biotechnology" and includes tools such as genetic
engineering. Biotechnology is also being used to improve crop plants.
How much have you heard or read about biotechnology? Would you
say you have read or heard...?
What is your overall impression of using biotechnology with plants
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that produce food products? Would you say?
As far as you know, are there any foods produced through
biotechnology in the supermarket now?
[If yes] Which foods would those be?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
[If yes] What benefits do you expect?
All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher?

34

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications?

22

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to reduce the
saturated fat content in the food?

25

All things being equal, how likely would you be to buy a food product
made with oils that had been modified by biotechnology to avoid trans
fats?

25

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to provide
more healthful fats, like Omega-3, in the food?

22

The U.S. Food and Drug Administration (FDA) requires special
labeling when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you strongly support, somewhat support, neither support nor
oppose, somewhat oppose or strongly oppose this policy of FDA?
During the past few months, have you taken any action or done
anything because of any concerns you may have about foods produced
using biotechnology?

7

And, how much have you read or heard about using biotechnology to
produce medicines from special varieties of food crops such as corn
and rice. Would you say you have heard?
What is your overall impression of using biotechnology to produce
medicines from food crops such as corn and rice? Would you say...?
Now I would like to talk to you about animal biotechnology. First of
all, how much have you read or heard about applying the science of
biotechnology to animals? Would you say you have heard?
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What is your overall impression of using biotechnology with animals
that produce food products such as meat, milk, and eggs? Would you
say...?

23

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can increase farm efficiency by increasing the amount of food
produced or decreasing the amount of feed needed by the animals.

19

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can improve the quality and safety of food (for example, through
improved animal health or improved nutritional quality of the food
produced).

15

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can reduce the environmental impact of animal waste.

16

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. Genomics is a form of
animal biotechnology that uses knowledge about the genetic makeup
of animals to aid in conventional breeding and selection. Would you
say that your overall impression of animal genomics is...

17

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. Genetic engineering is
a form of animal biotechnology that allows us to move beneficial traits
from one animal to another in a precise way. Would you say your
overall impression of genetic engineering in animals is…

28

If the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from animals enhanced through genetic
engineering were safe, how likely would you be to buy them? Would
you say?

35

Cloning is a form of animal breeding that retains desirable traits by
producing an animal that is an identical twin. Would you say your
overall impression of animal cloning is?

45

In some cases, animals that have been produced through cloning are
only used for breeding. Would you say your impression of this form of
animal biotechnology is?

40

Since the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from cloned animals were safe, how likely would

52
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you be to buy them? Would you say...?
Since the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from the offspring of cloned animals were safe,
how likely would you be to buy them? Would you say?

51

How much have you read or heard about the concept of sustainable
food production?
How important is it to you that the food products you purchased come
from a food producer that is enrolled in a scientifically validated
sustainability program? By sustainability, we mean to operate in a
manner, which does not jeopardize the availability of resources for
future generations.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Producing plants that
require less fresh water for growth, thereby conserving the world's
fresh water supply.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Increasing the
production of food staples in the world, thereby reducing world
hunger.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Reducing the amount
of pesticides needed to produce foods.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Creating high-yield
crops so valuable land like rain forests is NOT needed as growing
space for increased food production.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Using no till farming
methods, thereby reducing green house gas emissions.
(IFIC 2007)

Thinking about your diet over the last few months, are there any foods
or ingredients that you have avoided or eaten less of? [Biotech food]

0

[If yes] what foods or ingredients have you avoided?
Can you think of any information that is not currently included on food
labels that you would like to see on food labels? [Biotech food]

1

[If yes] What types of information would that be?
How confident are you about the safety of the US food supply? Would
you say...?
What, if anything, are you concerned about when it comes to food
safety? [Biotech]
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
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is called "biotechnology" and includes tools such as genetic
engineering. Biotechnology is also being used to improve crop plants.
How much have you heard...?
What is your overall impression of using biotechnology with plants
that produce food products? Would you say?

18

As far as you know, are there any foods produced through
biotechnology in the supermarket now?
[If yes] Which foods would those be?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
[If yes] What benefits do you expect?
All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher?

33

All things being equal, how likely would you be to buy a variety of
produce, like tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and required fewer
pesticide applications?

19

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to reduce the
saturated fat content in the food?

20

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to provide
more healthful fats, like Omega-3, in the food?

18

The U.S. Food and Drug Administration (FDA) requires special
labeling when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you strongly support, somewhat support, neither support nor
oppose, somewhat oppose or strongly oppose this policy of FDA?
During the past few months, have you taken any action or done
anything because of any concerns you may have about foods produced
using biotechnology?

5

[If yes] What actions have you taken?
And, how much have you read or heard about using biotechnology to
produce medicines from special varieties of food crops such as corn
and rice? Would you say you have heard...?
What is your overall impression of using biotechnology to produce
medicines from food crops such as corn and rice? Would you say...?
Now I would like to talk to you about animal biotechnology. First of
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all, how much have you read or heard about applying the science of
biotechnology to animals? Would you say you have heard...?
[If you] What did you read or hear about animal biotechnology?
What is your overall impression of using biotechnology with animals
that produce food products such as meat, milk, and eggs? Would you
say...?

23

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can increase farm efficiency by increasing the amount of food
produced or decreasing the amount of feed needed by the animals.

20

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can improve the quality and safety of food (for example, through
improved animal or improved animal health or improved nutritional
quality of the food produced).

12

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can reduce the environmental impact of animal waste.

14

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. First.... Genomics is a
form of animal biotechnology that uses knowledge about the genetic
makeup of animals to aid in conventional breeding and selection.
Would you say your overall impression of animals genomics is...?

22

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. First... Genetic
engineering is a form of animal biotechnology that allows us to move
beneficial traits from one animal to another in a precise way. Would
you say your overall impression of genetic engineering in animals is...?

30

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. First... Cloning is a
form of animal biotechnology that retains desirable traits by producing
an animal that is an identical twin. Would you say your overall
impression of animal cloning is...?

50

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,

42
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please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. First... In some cases,
animals that have been produced through cloning are only used for
breeding. Would you say your impression of this form of animal
biotechnology is…?
If the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from animals enhanced through genetic
engineering were safe, how likely would you be to buy them? Would
you say...?

39

And if the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from cloned animals were safe, how likely would
you be to buy them? Would you say...?

53

And if the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from the offspring of cloned animals were safe,
how likely would you be to buy them? Would you say...?
How much have you read or heard about the concept of sustainable
food production?

51

How important is it to you that the food products you purchase come
from a food producer that is enrolled in a scientifically validated
sustainability program? By sustainability, we mean to operate in a
manner, which does not jeopardize the availability of resources for
future generations.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Producing plants that
require less fresh water for growth, thereby conserving the world’s
fresh water supply.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Increasing the
production of food staples in the world, thereby reducing world
hunger.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Reducing the amount
of pesticides needed to produce food.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Creating high-yield
crops so valuable land like rain forests is NOT needed as growing
space for increased food production.
Please rank the following five factors related to growing crops in a
sustainable way in order of importance to you. Using no-till farming
methods, thereby reducing green house gas emissions.
(IFIC 2006)

Thinking about your diet over the last few months, are there any foods
or ingredients that you have avoided or eaten less of? [Biotech food]
[If yes] What foods or ingredients have you avoided?
Can you think of any information that is not currently included on food
labels that you would like to see on food labels? [Biotech food]
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0

1

[If yes] What?
How confident are you about the safety of the US food supply? Would
you say?

9

What, if anything, are you concerned about when it comes to food
safety? [Biotech food]
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called " biotechnology " and includes tools such as genetic
engineering. Biotechnology is also being used to improve crop plants.
How much have you heard or read about biotechnology? Would you
say you have read or heard...?
What is your overall impression of using biotechnology with plants
that produce food products? Would you say?

17

As far as you know, are there any foods produced through
biotechnology in the supermarket now?
[If yes] Which foods would those be?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
[If yes] What benefits do you expect?
All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher?

37

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications?

26

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to reduce the
saturated fat content in the food?

24

All things being equal, how likely would you be to buy a food product,
made with oils that had been modified by biotechnology to provide
more healthful fats, like Omega-3, in the food?

22

The U.S. Food and Drug Administration (FDA) requires special
labeling when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you strongly support, somewhat support, neither support nor
oppose, somewhat oppose or strongly oppose this policy of FDA?
[Of those that support or oppose] Why do you feel that way?
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During the past few months, have you taken any action or done
anything because of any concerns you may have about foods produced
using biotechnology?

2

[If yes] What actions have you taken?
And, how much have you read or heard about using biotechnology to
produce medicines from special varieties of food crops such as corn
and rice. Would you say you have heard?
What is your overall impression of using biotechnology to produce
medicines from food crops such as corn and rice? Would you say...?

6

Now I would like to talk to you about animal biotechnology. First of
all, how much have you read or heard about applying the science of
biotechnology to animals? Would you say you have heard?
[If yes] What did you read or hear about animal biotechnology?
What is your overall impression of using biotechnology with animals
that produce food products such as meat, milk, and eggs? Would you
say...?
Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can increase farm efficiency by increasing the amount of food
produced or decreasing the amount of feed needed by the animals.

24

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can improve the quality and safety of food (for example, through
improved animal health or improved nutritional quality of the food
produced.

15

Now, please read the following statements regarding the potential
benefits of animal biotechnology. As you read each one, please
indicate whether the information has a positive effect on your
impression, a negative effect, or no effect at all. Animal biotechnology
can reduce the environmental impact of animal waste.

13

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. Genomics is a form of
animal biotechnology that uses knowledge about the genetic makeup
of animals to aid in conventional breeding and selection. Would you
say that your overall impression of animal genomics is... ?

24

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. Genetic engineering is
a form of animal biotechnology that allows us to move beneficial traits

33
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from one animal to another in a precise way. Would you say your
overall impression of genetic engineering in animals is...?

(IFIC 2001)

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. Cloning is a form of
animal biotechnology that retains desirable traits by producing an
animal that is an identical twin. Would you say your overall
impression of animal cloning is...?

57

Animal biotechnology is a broad science, which is actually comprised
of a few major areas. As you read the brief description of each area,
please select the answer that corresponds with your overall impression
of that specific aspect of animal biotechnology. In some cases,
animals that have been produced through cloning are only used for
breeding. Would you say your impression of this form of animal
biotechnology is...?

46

If the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from animals enhanced through genetic
engineering were safe, how likely would you be to buy them? Would
you say?

42

And if the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from cloned animals were safe, how likely would
you be to buy them? Would you say...?

59

And if the U.S. Food and Drug Administration (FDA) determined that
meat, milk, and eggs from the offspring of cloned animals were safe,
how likely would you be to buy them? Would you say?
Thinking about your diet over the past few months, are there any foods
or ingredients that you have avoided or eaten less of?
Thinking about your diet over the past few months, are there any foods
or ingredients that you have avoided or eaten less of?

59

[If yes] What foods or ingredients did you avoid or eat less of?
[Biotech food]

6

[If yes] What foods or ingredients did you avoid or eat less of?
[Biotech food]

6

Can you think of any information that is not currently included on food
labels that you would like to see on food labels?
If yes, what? [Genetically altered food]

2

Can you think of any information that is not currently included on food
labels that you would like to see on food labels?
If yes, what? [Genetically altered food]

1

What, if anything are you concerned about when it comes to food
safety? [Genetically altered/engineered food]

2

What, if anything are you concerned about when it comes to food

2
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safety? [Genetically altered/engineered food]
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called biotechnology and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology?
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called biotechnology and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology?
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called biotechnology and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology?
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called biotechnology and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology?
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called biotechnology and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology?
As you may know, some food products and medicines are being
developed with the help of new scientific techniques. The general area
is called biotechnology and includes tools such as genetic engineering.
Biotechnology is also being used to improve crop plants. How much
have you heard or read about biotechnology?
As far as you know, are there any foods produced through
biotechnology in the supermarket now?
As far as you know, are there any foods produced through
biotechnology in the supermarket now?
If yes, which foods?
As far as you know, are there any foods produced through
biotechnology in the supermarket now?
If yes, which foods?
As far as you know, are there any foods produced through
biotechnology in the supermarket now?
If yes, which foods?
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As far as you know, are there any foods produced through
biotechnology in the supermarket now?
If yes, which foods?
As far as you know, are there any foods produced through
biotechnology in the supermarket now?
If yes, which foods?
All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher? Would you be very likely,
somewhat likely, not too likely, or not at all likely to buy these items?

43

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher? Would you be very likely,
somewhat likely, not too likely, or not at all likely to buy these items?
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All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher? Would you be very likely,
somewhat likely, not too likely, or not at all likely to buy these items?

43

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher? Would you be very likely,
somewhat likely, not too likely, or not at all likely to buy these items?

43

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher? Would you be very likely,
somewhat likely, not too likely, or not at all likely to buy these items?

38

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to taste better or fresher? Would you be very likely,
somewhat likely, not too likely, or not at all likely to buy these items?

42

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications? Would you be very likely, somewhat likely, not
too likely, or not at all likely?

23

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications? Would you be very likely, somewhat likely, not
too likely, or not at all likely?

21

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer

27
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pesticide applications? Would you be very likely, somewhat likely, not
too likely, or not at all likely?
All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications? Would you be very likely, somewhat likely, not
too likely, or not at all likely?

28

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications? Would you be very likely, somewhat likely, not
too likely, or not at all likely?

27

All things being equal, how likely would you be to buy a variety of
produce, like a tomatoes or potatoes, if it had been modified by
biotechnology to be protected from insect damage and require fewer
pesticide applications? Would you be very likely, somewhat likely, not
too likely, or not at all likely?

30

Biotechnology has also been used to enhance plants that yield food like
cooking oils. If cooking oil with reduced saturated fat made from
these new plants was available, what effect would the use of
biotechnology have on your decision to buy this cooking oil. Would
this have a positive effect, a negative effect, or no effect on your
purchase decision?

10

Biotechnology has also been used to enhance plants that yield food like
cooking oils. If cooking oil with reduced saturated fat made from
these new plants was available, what effect would the use of
biotechnology have on your decision to buy this cooking oil. Would
this have a positive effect, a negative effect, or no effect on your
purchase decision?

15

Biotechnology has also been used to enhance plants that yield food like
cooking oils. If cooking oil with reduced saturated fat made from
these new plants was available, what effect would the use of
biotechnology have on your decision to buy this cooking oil. Would
this have a positive effect, a negative effect, or no effect on your
purchase decision?

18

Biotechnology has also been used to enhance plants that yield food like
cooking oils. If cooking oil with reduced saturated fat made from
these new plants was available, what effect would the use of
biotechnology have on your decision to buy this cooking oil. Would
this have a positive effect, a negative effect, or no effect on your
purchase decision?

17

Biotechnology has also been used to enhance plants that yield food like
cooking oils. If cooking oil with reduced saturated fat made from
these new plants was available, what effect would the use of
biotechnology have on your decision to buy this cooking oil. Would
this have a positive effect, a negative effect, or no effect on your
purchase decision?

14
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Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
Do you feel that biotechnology will provide benefits for you or your
family within the next five years?
[If yes] What benefits do you expect?
The US Food and Drug Administration (FDA) requires special labeling
when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you support or oppose this policy of FDA?
The US Food and Drug Administration (FDA) requires special labeling
when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you support or oppose this policy of FDA?
The US Food and Drug Administration (FDA) requires special labeling
when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you support or oppose this policy of FDA?
The US Food and Drug Administration (FDA) requires special labeling
when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you support or oppose this policy of FDA?
The US Food and Drug Administration (FDA) requires special labeling
when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you support or oppose this policy of FDA?
The US Food and Drug Administration (FDA) requires special labeling
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when a food is produced under certain conditions: when
biotechnology's use introduces an allergen or when it substantially
changes the food's nutritional content, like vitamins or fat, or its
composition. Otherwise special labeling is not required. Would you
say that you support or oppose this policy of FDA?
Over the past few months, have you taken any action or done anything
because of any concerns you may have about foods produced using
biotechnology?

5

Over the past few months, have you taken any action or done anything
because of any concerns you may have about foods produced using
biotechnology?

5

How much have you read or heard regarding a recall of StarLink corn
products that were produced using biotechnology?
How much have you read or heard regarding a recall of StarLink corn
products that were produced using biotechnology?
(International Social
Survey Programme
2000)
(Lake Research
Partners 2010)

(Miller 1998)

Modifying the genes of certain crops is how dangerous for the
environment?

68

The Federal Food and Drug Administration may soon approve a new
laboratory-engineered salmon under a process designed to approve
veterinary drugs. Engineered salmon gain weight twice as fast as
normal salmon but we don't know the effect on human health. The
FDA has not conducted any health or environmental studies of its own
and has instead relied on the research from the technology company.
So do you think the FDA should APPROVE this genetically
engineered salmon for human consumption or should it NOT approve
this genetically engineered salmon?

78

If the FDA approves this genetically engineered salmon it will be the
first time any genetically engineered fish or animal has been approved
and allowed into the American food supply. Research is already
underway to put engineered pigs, chickens, and cattle into the food
supply once the salmon is approved, even though the FDA has
conducted no safety tests of its own. What do you think? Should the
FDA ALLOW these genetically engineered meats and fish into the
market before the FDA performs its own studies, or should it NOT
allow it until the FDA performs its own studies?

91

Do you think genetic engineering will improve our way of life in the
next 20 years, have no effect, or make things worse?

10

Do you think biotechnology will improve our way of life in the next 20
years, have no effect, or make things worse?

11

Over the last few months, have you heard or read anything about issues
involving modern biotechnology?
[If yes] What did you hear or read about modern biotechnology?
[If yes] How did you come to know about this information?
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If you wanted to know more about this topic, how would you get
information?
Have you heard or read about the cloning of a sheep named Dolly in
Scotland?
When you hear the term DNA, do you have a clear understanding of
what it means, a general sense of what it means, or little understanding
of what it means?
Now I am going to read you a list of applications, which may come out
of modern biotechnology. For each one, please tell me whether you
have heard of the application, then let me know whether you definitely
agree, tend to agree, tend to disagree, or definitely disagree with the
questions that follow. First, have you heard of using modern
biotechnology in the production of food and drinks, for example, to
make them higher in protein, keep longer, or taste better?
The use of modern biotechnology in the production of food and drinks
is useful for society. Do you definitely agree, tend to agree, tend to
disagree, or definitely disagree?

26

The use of modern biotechnology in the production of food and drinks
is risky for society. Do you definitely agree, tend to agree, tend to
disagree, or definitely disagree?

50

The use of modern biotechnology in the production of food and drinks
is morally acceptable for society. Do you definitely agree, tend to
agree, definitely disagree, or definitely disagree?

25

All in all, the use of modern biotechnology in the production of food
and drinks should be encouraged. Do you definitely agree, tend to
agree, tend to disagree, or definitely disagree?

31

Next, have you heard of using biotechnology to insert genes from one
plant into a crop plant to make it more resistant to insect pests?
Using biotechnology to insert genes from one plant to a crop plant is
useful for society. Do you definitely agree, tend to agree, tend to
disagree, or definitely disagree?

17

Using biotechnology to insert genes from one plant to a crop plant is
morally acceptable for society. Do you definitely agree, tend to agree,
tend to disagree, or definitely disagree?

20

Using biotechnology to insert genes from one plant to a crop plant is
risky for society. Do you definitely agree, tend to agree, tend to
disagree, or definitely disagree?

39

All in all, using biotechnology to insert genes form one plant into a
crop plant should be encouraged. Do you definitely agree, tend to
agree, tend to disagree, or definitely disagree?

24

Next, have you heard of using biotechnology to introduce human genes
into bacteria to produce medicines and vaccines, for example, the
production of insulin for people with diabetes?
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Using biotechnology to introduce human genes into bacteria to
produce medicines and vaccines is useful for society. Do you
definitely agree, tend to agree, tend to disagree, or definitely disagree?

9

Using biotechnology to introduce human genes into bacteria to
produce medicines and vaccines is risky for society. Do you definitely
agree, tend to agree, tend to disagree, or definitely disagree?

41

Using biotechnology to introduce human genes into bacteria to
produce medicines and vaccines is morally acceptable for society. Do
you definitely agree, tend to agree, tend to disagree, or definitely
disagree?

16

All in all, the use of modern biotechnology to introduce human genes
into bacteria to produce medicines and vaccines should be encouraged.
Do you definitely agree, tend to agree, tend to disagree, or definitely
disagree?

14

Next, have you heard of using biotechnology to introduce human genes
into animals to produce organs for human transplants, such as pigs for
human hearts?
Using biotechnology to introduce human genes into animals to produce
organs for human transplants is useful for society. Do you definitely
agree, tend to agree, tend to disagree, or definitely disagree?

40

Using biotechnology to introduce genes into animals to produce organs
for human transplants is risky for society. Do you definitely agree,
tend to agree, tend to disagree, or definitely disagree?

64

Using biotechnology to introduce genes into animals to produce organs
for human transplants is morally acceptable for society. Do you
definitely agree, tend to agree, tend to disagree, or definitely disagree?

51

All in all, using biotechnology to introduce human genes into animals
to produce organs for human transplants should be encouraged. Do
you definitely agree, tend to agree, tend to disagree, or definitely
disagree?

48

Next, have you heard of using genetic testing to determine whether an
unborn child has a genetic predisposition for a serious disease such as
cystic fibrosis?
Using genetic testing to determine whether an unborn child has a
genetic predisposition for a serious disease is useful for society. Do
you definitely agree, tend to agree, tend to disagree, or definitely
disagree?

19

Using genetic testing to determine whether an unborn child has a
genetic predisposition for a serious disease is risky for society. Do you
definitely agree, tend to agree, tend to disagree, or definitely disagree?

42

Using genetic testing to determine whether an unborn child has a
genetic predisposition for a serious disease is morally acceptable for
society. Do you definitely agree, tend to agree, tend to disagree, or

27
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definitely disagree?
All in all, using genetic testing to determine whether an unborn child
has a genetic predisposition for a serious disease should be
encouraged. Do you definitely agree, tend to agree, tend to disagree,
or definitely disagree?
Now I am going to read you a list of groups. For each of these groups,
if they made a public statement about the safety of biotechnology,
would you have a lot, some, or no trust in the statement about
biotechnology? First, the American Medical Association. Would you
have a lot of trust, some trust, or no trust in a statement made by the
American Medical Association about biotechnology?
The federal Food and Drug Administration. Would you have a lot of
trust, some trust, or no trust in a statement made by the Food and Drug
Administration about biotechnology?
Scientists from a university. Would you have a lot of trust, some trust,
or no trust in a statement made by scientists from a university in your
own state about biotechnology?
Food manufacturers. Would you have a lot of trust, some trust, or no
trust in a statement made by food manufacturers about biotechnology?
The National Institutes of Health. Would you have a lot of trust, some
trust, or no trust in a statement made by the National Institutes of
health about biotechnology?
Reporters on a television news show like 60 minutes. Would you have
a lot of trust, some trust, or no trust in a statement made by reporters
on a television news show like 60 minutes about biotechnology?
The U.S. Department of Agriculture. Would you have a lot of trust,
some trust, or no trust in a statement made by the Department of
Agriculture in your own state about biotechnology?
An article in Time or Newsweek. Would you have a lot of trust, some
trust, or no trust in a statement made by an article in Time or
Newsweek?
An article in Consumer Reports magazine. Would you have a lot of
trust, some trust, or no trust in a statement made by an article in
Consumer Reports magazine?
Now I'm going to read to you some statements such as those you might
find in a newspaper or magazine article. For each statement, please tell
me if you generally agree or generally disagree. If you feel especially
strongly about a statement, please tell me that you strongly agree or
strongly disagree. OK? First, the interested and informed citizen can
often have some influence on government policies toward science and
technology if he or she is willing to make the effort. Do you strongly
agree, agree, disagree, or strongly disagree?
Even if it brings no immediate benefits, scientific research, which
advances the frontiers of knowledge, is necessary and should be
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supported by the federal government. Do you strongly agree, agree,
disagree, or strongly disagree?
Scientists should be allowed to do research that causes pain and injury
to animals like dogs and chimpanzees if it produces new information
about human health problems. Do you strongly agree, agree, disagree,
or strongly disagree?
Current regulations are sufficient to protect people from any risks
linked to modern biotechnology. Do you strongly agree, agree,
disagree, or strongly disagree?

53

Biotechnology will personally benefit people like me in the next five
years. Do you strongly agree, agree, disagree, or strongly disagree?
My family and I have already benefited from biotechnology. Do you
strongly agree, agree, disagree, or strongly disagree?
The Bible is the actual word of God and is to be taken literally. Do you
strongly agree, agree, disagree, or strongly disagree?
Plants and animals exist primarily to be used by humans. Do you
strongly agree, agree, disagree, or strongly disagree?
The regulation of biotechnology should be left mainly to industry. Do
you strongly agree, agree, disagree, or strongly disagree?

78

Modern biotechnology is so complex that public involvement in the
policy process is a waste of time. Do you strongly agree, agree,
disagree, or strongly disagree?
There is a personal God who hears the prayers of individual men and
women. Do you strongly agree, agree, disagree, or strongly disagree?
It is not worth putting special labels on genetically modified foods. Do
you strongly agree, agree, disagree, or strongly disagree?

82

Animals have rights that people should not violate. Do you strongly
agree, agree, disagree or strongly disagree?
Now, please tell me whether you support or oppose the use of
biotechnology in agriculture and food production?

17

Please tell me why you support the use of biotechnology in agriculture
and food production?
Please tell me why you oppose the use of biotechnology in agriculture
and food production?
Do you support or oppose the use of biotechnology to develop new
medicines to treat human disease?
Please tell me why you support the use of biotechnology to develop
new medicines to treat human disease.
Please tell me why you oppose the use of biotechnology to develop
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new medicines to treat human disease.
There are differing views about whether people inherit particular
characteristics, that is whether people are born with these
characteristics, or whether they acquire them mainly from their
upbringing, or the conditions in which they lived. I am going to read
you a list of characteristics, and I would like you to tell me, for each
one, whether you think it is mainly inherited or mainly the result of
upbringing and living conditions. First, eye color. Is eye color mainly
inherited or mainly the result of upbringing and living conditions?
Next, intelligence. Is intelligence mainly inherited or mainly the result
of upbringing and living conditions?
A tendency to be happy. Is a tendency to be happy mainly inherited or
mainly the result of upbringing and living conditions?
Athletic abilities. Are athletic abilities mainly inherited or mainly the
result of upbringing and living conditions?
A person’s attitude toward work. Is a person’s attitude toward work
mainly inherited or mainly the result of upbringing and living
conditions?
Finally, musical abilities. Are musical abilities mainly inherited or
mainly the result of upbringing and living conditions?
Now I am going to read you a list of things that might happen within
the next 20 years as a result of modern biotechnology. For each one,
please say whether you think it is likely or unlikely to happen within
the next 20 years. First, substantially reducing environmental pollution.
Is this likely or unlikely to happen within the next 20 years?
Next, creating dangerous new diseases. Is this likely or unlikely to
happen within the next 20 years?

65

Substantially reducing world hunger. Is this likely or unlikely to
happen within the next 20 years?
Reducing the range of fruits and vegetables we can get. Is this likely or
unlikely to happen within the next 20 years?
Curing most genetic diseases. Is this likely or unlikely to happen
within the next 20 years?
Getting more out of natural resources in Third World countries. Is this
likely or unlikely to happen within the next 20 years?
Producing designer babies. Is this likely or unlikely to happen within
the next 20 years?
Replacing most existing food products with new varieties. Is this likely
or unlikely to happen within the next 20 years?
Now, let me return to a question about words and terms you may read
or hear in the news. Some articles refer to the results of a scientific
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study. When you read or hear the term scientific study do you have a
clear understanding of what it means, a general sense of what it means,
or little understanding of what it means?
In your own words, could you tell me what it means to study
something scientifically?
Now, please think about this situation. Two scientists want to know if a
certain drug is effective against high blood pressure. The first scientist
wants to give the drug to a 1000 people with high blood pressure and
see how many of them experience lower blood pressure levels. The
second scientist wants to give the drug to 500 people with high blood
pressure, and not give the drug to another 500 people with high blood
pressure, and see how many in both groups experience lower blood
pressure levels. Which is the better way to test this drug?
Why is it better to test the drug this way?
Now, I would like to ask you a few short quiz-type questions such as
you might see on a television game show. For each statement that I
read, please tell me if it is true or false. If you don't know or aren't sure,
just tell me so and we will skip to the next question. Remember: true,
false, or don't know. First, DNA regulates inherited characteristics in
all plants, animals, and humans. Is that true or false?
All bacteria are harmful to humans. Is that true or false?
Antibiotics kill viruses as well as bacteria. Is that true or false?
Senility is inevitable as the brain ages and loses tissue. Is that true or
false?
Given today’s biotechnology, scientists can now create new genes that
never existed in nature. Is that true or false?
More than half of human genes are identical to those with
chimpanzees. Is that true or false?
Viruses can be contaminated by bacteria. Is that true or false?
Human beings, as we know them today, developed from earlier species
of animals. Is that true or false?
The cloning of living things produces exactly identical offspring. Is
that true or false?
Yeast for brewing beer consists of living organisms. Is that true or
false?
Human beings can survive on almost any combination of foods,
provided that the total diet includes enough calories. Is that true or
false?
The human immune system has no defense against viruses. Is that true
or false?
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Ordinary tomatoes do not contain genes while genetically modified
tomatoes do. Is that true or false?
It is possible to find out in the first few months of pregnancy whether
or not an unborn child will have Downs Syndrome. Is that true or
false?
By eating a genetically modified fruit, a persons genes could also
become modified. Is that true or false?
It is impossible to transfer animal genes into plants. Is that true or
false?
Intelligence in humans is related to the size of the brain. Is that true or
false?
Genetically modified animals are always bigger than ordinary ones. Is
that true or false?
Now, think about this situation. A doctor tells a couple that their
genetic makeup means that they've got one in four chances of having a
child with an inherited illness. Does this mean that if their first three
children are healthy, the fourth will have the illness?
Does this mean that if their first child has the illness, the next three will
not?
Does this mean that each of the couple's children will have the same
risk of suffering from the illness?
Does this mean that if they have only three children, none will have the
illness?
We’ve been discussing several issues to do with modern
biotechnology. Some people think these issues are very important
while others don’t think so. On a scale from zero to ten where zero is
not at all important and ten is extremely important, how important are
these issues for you personally?

79

Now, using the same scale, how well informed would you say you are
about biotechnology, if zero means you are not at all informed about
biotechnology and ten means you are very well informed about
biotechnology.
Before today, had you ever talked about modern biotechnology with
someone? No, frequently, occasionally, or only once or twice?
Now, let me change the subject. During the last year, have you written
or spoken to any public official or legislator about any political issue or
problem?
(National Public
Radio 2000)

Thinking about major technological developments of the twentieth
century, which one or two of the following do you think were the most
significant?
For each of the following technologies, please tell me if you think it is
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making life better or worse for Americans, or isn't it making much
difference?
(NPR and Thomas
Reuters 2010)

On a scale of 1 to 5- where 1 is "Do Not Understand at All" and 5 is
"Understand Completely"- how well do you understand genetically
engineered foods?
What is your opinion regarding the safety of genetically engineered
foods?

79

Do you believe that foods should be labeled to indicate that they have
been genetically engineered or contain ingredients that have been
genetically engineered?

93

Would you eat the following foods knowing that they have been
genetically engineered? Fish.

65

Would you eat the following foods knowing that they have been
genetically engineered? Meat.

62

Would you eat the following foods knowing that they have been
genetically engineered? Vegetables, fruits, or grains.

40

Prior to today, did you know that some of the foods available in stores
today have been genetically engineered?
(Pew Initiative on
Food and
Biotechnology
2004)

How much responsibility do you have for making your household’s
shopping decisions? Are you completely responsible, partly
responsible, or not at all responsible for your household’s shopping
decisions?
How much have you seen, read or heard recently regarding the use of
biotechnology in the production of food that is sold in grocery stores?
Have you seen, read or heard a great deal, some, not too much, or
nothing at all recently regarding the use of biotechnology in the
production of food that is sold in grocery stores?
How much have you seen, read or heard recently regarding genetically
modified food that is sold in grocery stores? Have you seen, read or
heard a great deal, some, not too much, or nothing at all recently
regarding genetically modified food that is sold in grocery stores?
What have you heard about genetically modified foods?
Do you favor or oppose the introduction of genetically modified foods
into the US food supply?

47

How likely would you be to eat genetically modified foods? Would
you be very likely, somewhat likely, not too likely, or not at all likely
to eat genetically modified foods?

52

As far as you know, have you ever eaten genetically modified foods?
How much would you say you know about government regulation of
genetically modified food? Would you say you know a great deal,
some, not too much, or nothing at all about government regulation of
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genetically modified food?
Generally speaking, do you think there is [ROTATE] __too much
government regulation of genetically modified foods, __too little
regulation of genetically modified foods, or __the right amount of
regulation of genetically modified foods, or [ASK LAST] don’t you
have an opinion on this?

40

Do you think genetically modified foods are basically safe, basically
unsafe, or don’t you have an opinion on this?

27

Now, as you may know, more than half of products at the grocery store
are produced using some form of biotechnology or genetic
modification. Knowing this, do you think genetically modified foods
are basically safe, basically unsafe, or don’t you have an opinion on
this? Do you believe that strongly or not so strongly?

25

Currently, the FDA does not require companies to prove that
conventional foods are safe before they can be sold on the market, and
companies can bring new conventionally produced foods to the market
without prior approval from the FDA. The FDA can act to take a food
off the market if there's a safety problem. Now I’m going to read you
some goals that people have set out for the regulation of genetically
modified foods. After each I’d like you to tell me whether you favor or
oppose that goal. If you are not sure how you feel about a goal, just
say so and we will go on. Streamlining the process so that new
advances in genetically modified food are brought to market as soon as
possible.

50

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Requiring the FDA to
approve any genetically modified food as safe before it goes to market,
even if it causes substantial delays.

81

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Prohibiting any
genetically modified food from being sold in the United States, even if
the FDA believes it is safe.

36

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Ensuring that all
genetically modified foods are safe before they come to market.

85

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Removing any
genetically modified food deemed to be unsafe after it has come to
market.

85
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Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Balancing the interests
of consumers and food producers to provide the best and safest food.
Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Labeling all food that
is genetically modified.

92

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Labeling all processed
food that contains genetically modified ingredients.

91

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Genetically modified
foods should be subject to the same rules as new conventional foods.

12

Now I’m going to read you some goals that people have set out for the
regulation of genetically modified foods. After each I’d like you to tell
me whether you favor or oppose that goal. If you are not sure how you
feel about a goal, just say so and we will go on. Genetically modified
foods should be regulated more stringently than new conventional
foods.

72

Do you favor or oppose scientific research into genetic modifications
of animals?
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. You may choose any number
between 0 and 10. If you are not sure, please say so and we will move
on. Plants.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. You may choose any number
between 0 and 10. If you are not sure, please say so and we will move
on. Animals used for food sources, including cattle, fish and shrimp.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with

143

genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. You may choose any number
between 0 and 10. If you are not sure, please say so and we will move
on. Animals used for other purposes, including cats, dogs and
racehorses.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. You may choose any number
between 0 and 10. If you are not sure, please say so and we will move
on. Insects.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. You may choose any number
between 0 and 10. If you are not sure, please say so and we will move
on. Microbes, such as bacteria or algae.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. You may choose any number
between 0 and 10. If you are not sure, please say so and we will move
on. Humans.
Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To reduce the
need to use pesticides on crops.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To reduce the cost
of fish like salmon.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
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genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce more
affordable pharmaceutical drugs by using plants to produce
pharmaceutical compounds.
Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce more
affordable pharmaceutical drugs by using animals to produce
pharmaceutical compounds.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce more
affordable industrial compounds in plants including the materials used
to make plastics.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create new
types of grass that don't need to be mowed as often.

33

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create fruits
and vegetables that last longer on the store shelves.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce beef
with less fat.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To provide organs
for transplant to humans.

33

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To make it
possible to transplant animal organs to humans.

52
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To develop
vegetable oil with heart healthy fats.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create peanuts
that won't cause allergic reactions.

26

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To increase the
variety of available foods.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To expand our
understanding of science and nature.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To develop better
tasting fruits and vegetables.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce less
expensive food.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce less
expensive food to reduce hunger around the world.

20

Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To reduce the need to use pesticides on crops.
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Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To reduce the cost of fish, like salmon.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To produce more affordable pharmaceutical drugs by using plants
to produce pharmaceutical compounds.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To produce more affordable pharmaceutical drugs by using
animals to produce pharmaceutical compounds.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To produce more affordable industrial compounds in plants,
including the material used to make plastic.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To create new types of grass that don't need to be mowed as often.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To create fruits and vegetables that last longer on the store shelves.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To produce beef with less fat.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your

147

family. If you don’t know or aren’t sure, please say so and we’ll move
on. To provide organs for transplant to humans.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To make it possible to transplant animals organs to humans.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To develop vegetable oil with heart healthy fats.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To create peanuts that won't cause allergic reactions.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To increase the variety of available foods.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To expand our understanding of science and nature.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To develop better tasting fruits and vegetables.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
family. If you don’t know or aren’t sure, please say so and we’ll move
on. To produce less expensive food.
Now I’m going to read that same list of potential uses for genetic
modifications. After each, please tell me whether you think that use
would have a positive impact on you and your family, a negative
impact on you and your family, or no impact at all on you and your
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family. If you don’t know or aren’t sure, please say so and we’ll move
on. To produce less expensive food to reduce hunger around the
world.
(Pew Initiative on
Food and
Biotechnology
2003)

How much responsibility do you have for making your household’s
shopping decisions. Are you completely responsible, partly
responsible, or not at all responsible for your household’s shopping
decisions?
How much have you seen, read or heard recently regarding the use of
biotechnology in the production of food that is sold in grocery stores?
Have you seen, read or heard a great deal, some, not too much, or
nothing at all recently regarding the use of biotechnology in the
production of food that is sold in grocery stores?
How much have you seen, read or heard recently regarding genetically
modified food that is sold in grocery stores? Have you seen, read or
heard a great deal, some, not too much, or nothing at all recently
regarding genetically modified food that is sold in grocery stores?
What have you heard about genetically modified foods? Please be as
specific as possible.
Do you favor or oppose the introduction of genetically modified foods
into the US food supply?

48

How likely would you be to eat genetically modified foods? Would
you be very likely, somewhat likely, not too likely, or not at all likely
to eat genetically modified foods?

50

As far as you know, have you ever eaten genetically modified foods?
Recently, the United States launched a complaint against the European
Union, because they were banning certain agricultural products that
have been genetically modified. How much, if anything, have you
happened to hear about this? Have you heard a great deal, some, not
too much, or nothing at all about this?
Based on what you have heard, would you say you favor or oppose this
complaint against the European Union’s ban on certain genetically
modified food, or aren’t you sure?
How much would you say you know about government regulation of
genetically modified food? Would you say you know a great deal,
some, not too much, or nothing at all about government regulation of
genetically modified food?
Generally speaking, do you think there is ROTATE __too much
government regulation of genetically modified foods, __too little
regulation of genetically modified foods, or __the right amount of
regulation of genetically modified foods, or [ASK LAST] don’t you
have an opinion on this?

35

Do you think genetically modified foods are basically safe, basically
unsafe, or don’t you have an opinion on this?

24
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Now, as you may know, more than half of products at the grocery store
are produced using some form of biotechnology or genetic
modification. Knowing this, do you think genetically modified foods
are basically safe, basically unsafe, or don’t you have an opinion on
this? Do you believe that strongly or not so strongly?

24

Which of the following statements best reflects your opinion about
genetically modified foods: [ROTATE STATEMENTS] Genetically
modified foods are essentially the same as other foods because people
have been modifying foods through conventional breeding for
hundreds of years, and genetic modification is just a new way of doing
the same things OR Genetically modified foods are different from
other foods because most of the changes allowed by genetic
modification are impossible to do with conventional breeding OR
[ASK LAST] Aren't you sure?

42

Currently, the FDA does not require companies to prove that
conventional foods are safe before they can be sold on the market, and
companies can bring new conventionally produced foods to the market
without prior approval from the FDA. Now I’m going to read you
some statements that people have said about the Food and Drug
Administration’s rules regarding genetically modified foods. After
each I’d like you to tell me whether you agree or disagree with the
statement. If you aren't sure how you feel about a statement, just say so
and we will go on. Companies should be allowed to put a genetically
modified food on the market without any special review by the Food
and Drug Administration, if the company can show it is as safe as any
other food.

61

Now I’m going to read you some statements that people have said
about the Food and Drug Administration’s rules regarding genetically
modified foods. After each I’d like you to tell me whether you agree or
disagree with the statement. If you aren't sure how you feel about a
statement, just say so and we will go on. Companies should be
encouraged, but not required, to let the Food and Drug Administration
review data regarding the safety of a genetically modified food before
that product goes on the market.
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Now I’m going to read you some statements that people have said
about the Food and Drug Administration’s rules regarding genetically
modified foods. After each I’d like you to tell me whether you agree or
disagree with the statement. If you aren't sure how you feel about a
statement, just say so and we will go on. Companies should be
required to submit safety data to the Food and Drug Administration for
review, and no genetically modified food product should be allowed on
the market until the FDA determines it is safe.

89

Now I’m going to read you some statements that people have said
about the Food and Drug Administration’s rules regarding genetically
modified foods. After each I’d like you to tell me whether you agree or
disagree with the statement. If you aren't sure how you feel about a
statement, just say so and we will go on. Genetically modified foods
should not be allowed to be sold even if the Food and Drug
Administration believes they are safe.

28

Currently, the Food and Drug Administration reviews data regarding
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the safety of genetically modified foods that is voluntarily submitted
by food companies. If the federal government changed its rules so that
it became mandatory for the FDA to approve all genetically modified
foods before it entered the market place, would you be [ROTATE]
__more willing to eat genetically modified foods, __less willing to eat
genetically modified foods, or [ASK LAST] would it not make a
difference in how willing you would be to eat genetically modified
foods?
Now, as you may know, more than half of products at the grocery store
are produced using some form of biotechnology or genetic
modification. Knowing this, do you think genetically modified foods
are basically safe, basically unsafe, or don’t you have an opinion on
this? Do you believe that strongly or not so strongly?
Do you favor or oppose scientific research into genetic modifications
of animals?
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. If you are not sure, please say
so and we will move on. Plants.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. If you are not sure, please say
so and we will move on. Animals used for food sources, including
cattle, fish and shrimp.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. If you are not sure, please say
so and we will move on. Animals used for other purposes, including
cats, dogs and race horses.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. If you are not sure, please say
so and we will move on. Insects.
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Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. If you are not sure, please say
so and we will move on. Microbes, such as bacteria or algae.
Now I'm going to list some life forms which can be genetically
modified. After each, please tell me how comfortable you are with
genetic modification of that specific life form. Use a scale of zero to
ten where zero means that you are very uncomfortable with genetic
modifications of that life form, and ten means that you are very
comfortable with genetic modification of that life form. 5 is neutral,
neither uncomfortable nor comfortable. If you are not sure, please say
so and we will move on. Humans.
Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To reduce the
need to use pesticides on crops.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To reduce the
cost of fish, like salmon.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce more
affordable pharmaceutical drugs by using plants to produce
pharmaceutical compounds.

14

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce more
affordable pharmaceutical drugs by using animals to produce
pharmaceutical compounds.

41

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce more
affordable industrial compounds in plants, including the material used
to make plastic.

28
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create goats
whose milk can be used to produce industrial products like extremely
strong silk, which can be used to make bulletproof vests.
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Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create new
types of grass that don’t need to be mowed as often.

33

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create fruits
and vegetables that last longer on the store shelves.

41

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To produce beef
with less fat.

43

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To provide
organs for transplant to humans.

35

Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To develop
vegetable oil with heart healthy fats.
Now I’m going to list some reasons to genetically modify plants or
animals. For each item I read, please tell me if you think it is a good
reason to genetically modify plants or animals, or a bad reason to
genetically modify plants or animals. If you aren’t sure how you feel
about a specific item, just say so and we’ll move on. To create peanuts
that won’t cause allergic reactions.

25

Please tell me how important each of the following are in determining
whether or not you favor genetic modifications of plants and animals.
After each, please tell me whether it is very important, somewhat
important, not too important, or not at all important in determining
whether or not you favor genetic modifications of plants and animals.
If you aren’t sure about a specific item, please say so and we’ll move
on. Your religious beliefs.
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Please tell me how important each of the following are in determining
whether or not you favor genetic modifications of plants and animals.
After each, please tell me whether it is very important, somewhat
important, not too important, or not at all important in determining
whether or not you favor genetic modifications of plants and animals.
If you aren’t sure about a specific item, please say so and we’ll move
on. The science involved.
Please tell me how important each of the following are in determining
whether or not you favor genetic modifications of plants and animals.
After each, please tell me whether it is very important, somewhat
important, not too important, or not at all important in determining
whether or not you favor genetic modifications of plants and animals.
If you aren’t sure about a specific item, please say so and we’ll move
on. Your ethical beliefs.
Please tell me how important each of the following are in determining
whether or not you favor genetic modifications of plants and animals.
After each, please tell me whether it is very important, somewhat
important, not too important, or not at all important in determining
whether or not you favor genetic modifications of plants and animals.
If you aren’t sure about a specific item, please say so and we’ll move
on. The impact it might have on you and your family.
Please tell me how important each of the following are in determining
whether or not you favor genetic modifications of plants and animals.
After each, please tell me whether it is very important, somewhat
important, not too important, or not at all important in determining
whether or not you favor genetic modifications of plants and animals.
If you aren’t sure about a specific item, please say so and we’ll move
on. The trust you have in the people providing information.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Religious leaders.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Scientists and
academics.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Government
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regulators.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. The Food and Drug
Administration, or FDA.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Biotechnology
companies.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Consumer groups.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Environmental
groups.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Food manufacturers.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Farmers.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
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organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. The news media.
Now I’m going to read you a list of groups and organizations from
which you can get information about genetically modified foods. After
each, please tell me how much you trust what each group or
organization says about genetically modified foods. Do you trust what
they have to say about genetically modified foods a great deal, some,
not too much, or not at all? If you have never heard of the organization,
or don’t know, please say so and we’ll move on. Friends and family.
(Pew Initiative on
Food and
Biotechnology
2001)

How much responsibility do you have for making your household’s
shopping decisions. Are you completely responsible, partly
responsible, or not at all responsible for your household’s shopping
decisions?
Overall, do you have a very favorable, somewhat favorable, somewhat
unfavorable, or very unfavorable impression of genetically modified
foods?

44

Overall, do you have a very favorable, somewhat favorable, somewhat
unfavorable, or very unfavorable impression of biotechnology used in
food production?

30

Overall, do you have a very favorable, somewhat favorable, somewhat
unfavorable, or very unfavorable impression of irradiated foods?

25

Overall, do you have a very favorable, somewhat favorable, somewhat
unfavorable, or very unfavorable impression of organic foods?

15

I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Biotechnology being used in
the production of food.

62

I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Genetically modified foods.
I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Chemicals and fertilizers being
used in the production of food.

61

I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Listeria.

40
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I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Irradiation.

50

I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Food poisoning.

84

I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Salmonella.

84

I'm going to list some things people tell us they are concerned about
when it comes to food safety. After each, please tell me whether it is
one of the things that worries you most about food safety, whether it
worries you a great deal, some, not too much, or not at all. If you are
not sure, please say so and we'll go on. Food freshness.

89

How much have you seen, read or heard recently regarding the use of
biotechnology in the production of food that is sold in grocery stores?
Have you read, seen or heard a great deal, some, not too much, or
nothing at all recently regarding the use of biotechnology in the
production of food that is sold in grocery stores?
How much have you seen, read or heard recently regarding genetically
modified food that is sold in grocery stores? Have you heard a great
deal, some, not too much, or nothing at all recently regarding
genetically modified food that is sold in grocery stores?
Do you favor or oppose the introduction of genetically modified foods
into the US food supply?

58

How likely would you be to eat genetically modified foods? Would
you be very likely, somewhat likely, not too likely, or not at all likely
to eat genetically modified foods?

54

As far as you know, have you ever eaten genetically modified foods?
When you go to the grocery store how important is it to you to know
whether a product contains genetically modified agricultural products?
Is it very important, somewhat important, not too important, or not at
all important for you to know whether a product contains genetically
modified agricultural products?
To the best of your knowledge, how much of the food in a typical
American grocery store is genetically modified -- that is, food
modified through biotechnology or contains genetically modified
ingredients?
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Do you think genetically modified foods are basically safe, basically
unsafe, or don’t you have an opinion on this?

24

Now, as you may know, more than half of products at the grocery store
are produced using some form of biotechnology or genetic
modification. Knowing this, do you think genetically modified foods
are basically safe, basically unsafe, or don’t you have an opinion on
this?

22

Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. The Food and Drug Administration, or
FDA.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. The Environmental Protection Agency, or
EPA.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Grocery stores.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Farmers.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Environmental groups.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
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all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Food Safety groups.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Food manufactures.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Consumer groups.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Scientists and academics.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Local community leaders.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Research centers.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at
all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Friends and family.
Now I’m going to read you a list of organizations from which you can
get information about genetically modified foods. After each, please
tell me how much you trust what each organization says about
genetically modified foods. Do you trust what they have to say about
genetically modified foods a great deal, some, not too much, or not at

159

all? If you have never heard of the organization, or don’t know, please
say so and we’ll move on. Elected Officials.
Do you favor or oppose scientific research into genetic modifications
of food?
Have you heard any stories in the news recently about genetically
modified foods?
Recently, a number of food companies recalled taco shells and other
corn products from grocery stores because they were found to contain
a type of genetically modified corn that had not been cleared for
human consumption. How much if anything have you happened to
hear about this? Have you heard a great deal, some, not too much, or
nothing at all?
How concerned are you about this food recall [StarLink]? Are you
very concerned, somewhat concerned, not too concerned, or not at all
concerned?
Have you changed your food purchasing habits as a result of this recall
[StarLink]?

74
22

How much, if anything, have you heard in the news recently about
genetically modified rice that might help reduce cases of children’s
blindness in the developing world? Have you happened to hear a great
deal, some, not too much, or nothing at all?
(Slovic 1993)

For the next items, please indicate your opinion on the health risks
only for the American public as a whole. For each item, please tell me
whether you think there is almost no health risk, slight health risk,
moderate health risk, or high health risk for the American public as a
whole. [Use of genetically engineered bacteria in agriculture]

(Smith, Marsden,
Hout, and Kim
2011)

Ordinary tomatoes do not contain genes, while genetically modified
tomatoes do. True or False?
Here is another public issue: genetically modified foods. Genetically
modified foods come from plants or animals whose characteristics
have been changed by the alteration, addition, or deletion of DNA in
their genetic material using advanced laboratory techniques. Some say
that genetically modified foods are unsafe and pose risks for human
health. Others say that they are safe and necessary to reduce world
hunger. How well do the following groups understand the risks posed
by genetically modified foods? Medical researchers.
Here is another public issue: genetically modified foods. Genetically
modified foods come from plants or animals whose characteristics
have been changed by the alteration, addition, or deletion of DNA in
their genetic material using advanced laboratory techniques. Some say
that genetically modified foods are unsafe and pose risks for human
health. Others say that they are safe and necessary to reduce world
hunger. How well do the following groups understand the risks posed
by genetically modified foods? Elected Officials.
Here is another public issue: genetically modified foods. Genetically
modified foods come from plants or animals whose characteristics
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have been changed by the alteration, addition, or deletion of DNA in
their genetic material using advanced laboratory techniques. Some say
that genetically modified foods are unsafe and pose risks for human
health. Others say that they are safe and necessary to reduce world
hunger. How well do the following groups understand the risks posed
by genetically modified foods? Business leaders.
To what extent do medical researchers agree on the risks and benefits
of genetically modified foods?
Some say that the government should restrict the sale of genetically
modified foods. Others say there is no need for such restrictions. How
much influence should each of the following groups have in deciding
whether to restrict the sale of genetically modified foods? Medical
Researchers.
Some say that the government should restrict the sale of genetically
modified foods. Others say there is no need for such restrictions. How
much influence should each of the following groups have in deciding
whether to restrict the sale of genetically modified foods? Elected
officials.
Some say that the government should restrict the sale of genetically
modified foods. Others say there is no need for such restrictions. How
much influence should each of the following groups have in deciding
whether to restrict the sale of genetically modified foods? Business
leaders.
When making policy recommendations about genetically modified
foods, to what extent do you think the following groups would support
what is best for the country as a whole or what serves their own narrow
interests? Medical Researchers.

13

When making policy recommendations about genetically modified
foods, to what extent do you think the following groups would support
what is best for the country as a whole or what serves their own narrow
interests? Elected Officials.

48

When making policy recommendations about genetically modified
foods, to what extent do you think the following groups would support
what is best for the country as a whole or what serves their own narrow
interests? Business leaders.

63

Which statement best describes your own view about eating foods that
have been genetically modified? [I don't care whether the food I eat has
been genetically modified. I am willing to eat genetically modified
foods, but would prefer unmodified foods if they are available. I will
not eat food that I know has been genetically modified.

82

The cloning of living things produces genetically identical copies.
True or False?
Here is a list of some different environmental problems. Which
problem, if any, do you think is the most important for America as a
whole? [Genetically modified foods]
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3

Which problem, if any, affects you and your family the most?
[Genetically modified foods]

0

If you wanted to learn about scientific issues such as global warming
or biotechnology, where would you get information? The newspapers,
magazines, the internet, books or other printed materials, TV, radio,
government agencies, family, friends, colleagues, or some other
source?
If you wanted to learn about scientific issues such as global warming
or biotechnology, where would you get information? The newspapers,
magazines, the internet, books or other printed materials, TV, radio,
government agencies, family, friends, colleagues, or some other
source?
If you wanted to learn about scientific issues such as global warming
or biotechnology, where would you get information? The newspapers,
magazines, the internet, books or other printed materials, TV, radio,
government agencies, family, friends, colleagues, or some other
source?
(Taylor 2000)

How much have you seen, read, or heard about new types of plants and
crops, which have been genetically engineered- a lot, some, not much,
or nothing at all?
How much have you seen, read, or heard about new genetically
modified foods- a lot, some, not much, or nothing at all?
How likely do you think it is that the following will happen because of
the use of new types of plants and crops developed by genetic
engineering- very, somewhat, not very, or not at all likely? Food based
on these new crops will be poisonous or cause disease in people who
eat them.

45

How likely do you think it is that the following will happen because of
the use of new types of plants and crops developed by genetic
engineering- very, somewhat, not very, or not at all likely?
Agricultural production will increase.
How likely do you think it is that the following will happen because of
the use of new types of plants and crops developed by genetic
engineering- very, somewhat, not very, or not at all likely? They will
upset the balance of nature and damage the environment.

56

How likely do you think it is that the following will happen because of
the use of new types of plants and crops developed by genetic
engineering- very, somewhat, not very, or not at all likely? They will
make food less expensive than it would be otherwise.
Do you think the government should require the labeling of all
packaged and other food products stating that they include corn, soy or
other products which have come from genetically modified crops, or is
that not important?

86

Overall do you think the benefits of developing and growing these new
plants and crops outweigh the risks of doing this, or do you think the

48
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risks outweigh the benefits?
(Taylor 1993)

In the movie, 'Jurassic Park, scientists build a theme park containing
real dinosaurs that were cloned from ancient biological cells that were
fossilized. How likely do you think it would be for real scientists to
take ancient genetic material and clone copies of animals, plants and
even dinosaurs -- very likely somewhat likely, not very likely or not
likely at all?
In 'Jurassic Park' the dinosaurs were supposedly produced by genetic
engineering. Genetic engineering means the process of changing genes
or DNA in a cell for medical, agricultural or other scientific research.
On balance, do you believe that the potential benefits of genetic
engineering outweigh the risks or that the risks outweigh the potential
benefits?

57

How likely do you think it is that animals, plants or bacteria which are
produced by genetic engineering will pose a serious threat to human
life or the environment-- very likely, somewhat likely, not very likely,
or not likely at all?

60

*If taken as an indicator of concern
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Appendix E. Codebook for Dataset
Information
Code
Description
Question Identification
1-569
Each question was given an identification code ranging from one
through 569
Source Identification

1
2
3
4
5
6
7
8
9
10
11
12

ABC
CBS
Gallup Poll
Harris Poll
Harris Interactive and the Chicago Council on Foreign Relations
IFIC
ISSP
ICPSR
Lake Research Partners
NPR
Pew Initiative on Food and Biotechnology
Thomas Reuters and NPR

Year Study Conducted

19932010

The year the study was conducted, if the study spanned across
multiple years, the last year was recorded

Question Type

1
2
3
4
5
6
7
8
9
10

Seven-point Likert Scale
Six-Point Likert-Type Scale
Five-point Likert-Type Scale
Four-Point Likert-Type Scale
Trichotomous
Dichotomous
Open-Ended
Ranked
Multiple Choice
Scale

Response Type

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Degree of Confidence
Safe or Not
Yes or No
Likelihood of Phenomena
Should or Should Not
Amount of Information Obtained
Degree of Favorability
Support or Oppose
Positive or Negative Reaction to Statement
Degree of Importance
Degree of Danger
Greater Risk or Greater Benefit
Level of Understanding
Level of Agreement
Level of Trust
Support or Oppose
Inheritance or Environmental
Understand or Not
True or False
Frequency of Event
Right or Wrong
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22
23
24
25
26
27
99

Degree of Influence
Level of Responsibility
Same as Conventional or Not
Degree of Concern, Confidence or Worry
Favor or Oppose
Good or Bad
Missing: Open-ended or Multiple Choice

Collection Method

1
2
3
4
5

Telephone
Web
In-Person
Mixed
Written

Scope

0
1

Localized
National

Linguistic Facet

BIO
GM
GE
GA

Biotechnology
Genetic Modification
Genetic Engineering
Genetic Alteration

Theoretical Facet

BEL
KNOW
ATT
VC
AC

Belief
Objective Knowledge
Attitude or Affect
Conative Behavior
Actual Behavior

Spatial Facet

LOC
NS
GLO
NA

Local
Nation State
Global
Not Specified

Temporal Facet

PAST
PRES
FUT

Past
Present
Future

Substantive Facet

GMF
GMC
ANIM
MED
HUM
ENV
REG
LAB
ECON
CLON
PEST
HUNG

Genetically Modified Food
Genetically Modified Crops
Genetically Modified Animals
Medical Use
Human Health Issue
Environmental Health Issue
Regulation
Labeling
Economics
Cloning
Pesticide Use
Human Hunger Issue
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Appendix F-1. Description of Excel Function and List of Key Words by Dimension
To increase the reliability in coding each question, I wrote an Excel function that would code each
question according to parameters I set. Using the IF, SUM and COUNTIF formulas, the function dummy
coded each dimension for every indicator. The coding was discriminated based on key words that I
developed for each category. The function takes the following form:
=IF(SUM(COUNTIF(Cell Position, {Key word 1, key word 2… key word X}))>0,1,0)
Basically, this function dummy codes every quesrion for every dimension according to the key words I
specified. In the above function, “cell position” indicates the location of the question in the Excel sheet.
The function is interpreted as: if the sum of the number of key words appearing in the specified question
exceeds zero then assign the cell one, otherwise assign the cell zero. Appendix Table 1. specifies the key
words for each dimension by facet. Notice that the key words for each dimension are not exclusive.
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Table F1. Key Words for Dimensions by Facet
Facet
Dimension
Key Words
Linguistic
Biotechnology
Biotech, Bioengineered, Biotechnology

Theoretical

Spatial

Temporal

Substantive

Genetic Modification

GM, Modification, Modified, Modify

Genetic Engineering

GE, Engineered, Engineering

Genetic Alteration

GA, Alteration, Altered

Belief

As Far As, How Likely, How Much, Opinion, Tell Me

Knowledge

Informed, Meaning, Percentage, Understand

Attitude

Good/Bad, Impression, Risk

Conative Behavior

Effect On, Would You

Actual Behavior

Do You, Have You, How Did You, Taken Action

Local

Impact, Personally, Your Family, Your Market

National

American, Federal, National, United States, 60 Minutes

Global

Global, EU, Scotland, World

Past

Avoided, Before, Few Months, Have You, Prior, Recall, What
Did, What Were

Present

Agree, Are You, Do You, How Concerned, Impression, Opinion,
Rate, You Have, You Think, Worries You

Future

How Likely, If You Saw, Is This Likely, Will Improve, Would
You

Food

Eat, Food

Crops

Agriculture, Corn, Crop, Fruit, Plant, Produce, Starlink, Tomatoes

Animal Use

Animal, Beef, Egg, Fish, Livestock, Meat, Milk, Poultry, Salmon,
Sheep

Medical Use

Antibiotics, Curing, Medicare, Medicine, Transplant

Human Health

Allergic, Allergen, Consumption, Disease, Eat, Fat, Illness, Safe,
Threat, Warning

Environmental Health

Environment, Fresh Water, Green House, Nature, Resources

Regulation

Ban, FDA, Food Recall, Government, Label, Prohibit, USDA,
Regulate, Rules

Labeling

Label

Economics

Afford, Buy, Consumer, Cost, Expensive, Product, Purchase,
Market, Spend, Sold

167

Cloning

Dolly, Clone, Cloning

Pesticide Use

Bug, Chemical, Herbicide, Insecticide, Pest

Human Hunger

Hunger, Production

Other

Better Taste, Fast Growth, Genetic Test, Irradiated, Listeria,
Nutritional, Organic, Research, Sustainability
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